| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KATNAL2 MYO1A MYO10 SPTBN1 EML6 PEX14 CLASP2 SYNPO CLIP1 KLHL20 NPC1L1 GOLGA2 VCL KIF2C CACNA1C RANBP10 KIF6 HDAC6 GIT1 DCTN2 ARFGEF2 DPYSL4 PPARG LRPPRC SLC8A1 AFAP1 XIRP2 INF2 MACF1 AATF SSH2 MYO15A SCIN MYO16 | 3.58e-05 | 1099 | 294 | 34 | GO:0008092 |
| GeneOntologyMolecularFunction | calcium ion binding | EFCAB5 DCHS2 MATN3 CIB4 SVEP1 RYR1 PCDH17 ITPR3 DUOX1 CPNE6 DSG3 ANXA6 PCDHB15 PCDHB11 DUOX2 TGM3 SLC8A1 VCAN LRP4 MACF1 SCIN ATP2A1 CDH2 CDH3 CDH4 CDH15 | 4.94e-05 | 749 | 294 | 26 | GO:0005509 |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol binding | 9.42e-05 | 17 | 294 | 4 | GO:0005545 | |
| GeneOntologyMolecularFunction | NADH oxidase H202-forming activity | 2.16e-04 | 2 | 294 | 2 | GO:0106293 | |
| GeneOntologyMolecularFunction | monoatomic ion antiporter activity involved in regulation of postsynaptic membrane potential | 2.16e-04 | 2 | 294 | 2 | GO:0099580 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | DOCK4 ARHGAP32 SPTBN1 SRF CLASP2 DCC SVEP1 WASHC5 ANAPC2 FGA HRH1 WNK3 PLXNA3 CACNA1C NPR3 DRD1 HDAC6 SLC8A1 INF2 MACF1 SSH2 ARHGAP18 SCIN CDH4 WDTC1 | 2.92e-06 | 618 | 293 | 25 | GO:0090066 |
| GeneOntologyBiologicalProcess | cell junction organization | GABRG3 RELN MYCBP2 SRF CLASP2 SYNPO SVEP1 PCDH17 CPNE6 LRFN2 ANAPC2 PKP2 SNX27 VCL KIF2C WHRN DRD1 HDAC6 PPFIBP1 FRMPD2 PCDHB11 ADGRL1 SLC8A3 XIRP2 LRP4 MACF1 PEAK1 PRRT1 CDH2 CDH3 CDH4 CDH15 | 9.54e-06 | 974 | 293 | 32 | GO:0034330 |
| GeneOntologyBiologicalProcess | axon extension | ARHGAP32 SRF CLASP2 ANAPC2 VCL PLXNA3 HDAC6 AUTS2 MACF1 CDH4 | 2.37e-05 | 135 | 293 | 10 | GO:0048675 |
| GeneOntologyCellularComponent | anchoring junction | DCHS2 ATP7B CLASP2 SYNPO YAP1 AMOTL1 PKP2 WNK3 VCL GIT1 DSG3 PPFIBP1 ANXA6 FRMPD2 ARHGAP17 DUOX2 PPL TGM1 SLC8A1 SLC8A3 AFAP1 XIRP2 CSPG4 ABCB11 SSH2 PEAK1 SCIN CDH2 CDH3 CDH4 CDH15 | 2.26e-05 | 976 | 295 | 31 | GO:0070161 |
| GeneOntologyCellularComponent | axon | MYC RELN MYO1A MYCBP2 SPTBN1 GARS1 NCAM2 CLASP2 SYNPO DCC KLHL20 STAT1 CPNE6 SYNJ2 WHRN CACNA1C DRD1 HDAC6 HDAC5 GIT1 AZIN2 DCTN2 HCN1 ADGRL1 SLC8A1 SLC8A3 OPTN AUTS2 WDFY3 | 2.70e-05 | 891 | 295 | 29 | GO:0030424 |
| GeneOntologyCellularComponent | cell leading edge | GABRG3 MYO1A MYO10 SPTBN1 GDPD2 CLASP2 CLIP1 DUOX1 SYNJ2 AMOTL1 HDAC6 GIT1 HCN1 DUOX2 CSPG4 MACF1 ARHGAP18 ARHGEF26 ARHGAP45 CDH2 | 3.15e-05 | 500 | 295 | 20 | GO:0031252 |
| GeneOntologyCellularComponent | supramolecular fiber | MYBPH KATNAL2 MYO1A SPTBN1 EML6 GDPD2 CLASP2 SYNPO CLIP1 RYR1 SYNJ2 PKP2 GOLGA2 VCL KIF2C WHRN CACNA1C KIF6 HDAC6 DYNC2H1 DCTN2 CEP162 ARFGEF2 PPL LRPPRC SLC8A1 SLC8A3 AFAP1 XIRP2 INF2 MACF1 ARHGAP18 ATP2A1 | 1.42e-04 | 1179 | 295 | 33 | GO:0099512 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | MYC RGPD4 ATP7B BAG1 KLHL20 STAT1 RYR1 ITPR3 RAB4B SYNJ2 KCND3 RGPD3 RAB4A GOLGA2 WHRN HDAC6 AZIN2 ANXA6 ARFGEF2 NDFIP2 PPARG PACS1 LRPPRC SLC8A3 OPTN INF2 ASL MYO16 | 1.52e-04 | 934 | 295 | 28 | GO:0048471 |
| GeneOntologyCellularComponent | supramolecular polymer | MYBPH KATNAL2 MYO1A SPTBN1 EML6 GDPD2 CLASP2 SYNPO CLIP1 RYR1 SYNJ2 PKP2 GOLGA2 VCL KIF2C WHRN CACNA1C KIF6 HDAC6 DYNC2H1 DCTN2 CEP162 ARFGEF2 PPL LRPPRC SLC8A1 SLC8A3 AFAP1 XIRP2 INF2 MACF1 ARHGAP18 ATP2A1 | 1.61e-04 | 1187 | 295 | 33 | GO:0099081 |
| GeneOntologyCellularComponent | actin cytoskeleton | ARHGAP32 MYO1A MYO10 SPTBN1 GDPD2 SYNPO KLHL20 VCL WHRN DCTN2 AFAP1 XIRP2 INF2 AUTS2 MACF1 PEAK1 MYO15A SCIN CDH2 MYO16 | 2.15e-04 | 576 | 295 | 20 | GO:0015629 |
| GeneOntologyCellularComponent | plasma membrane raft | 2.47e-04 | 147 | 295 | 9 | GO:0044853 | |
| GeneOntologyCellularComponent | cell-cell junction | DCHS2 ATP7B SYNPO YAP1 AMOTL1 PKP2 WNK3 VCL DSG3 ANXA6 FRMPD2 ARHGAP17 PPL TGM1 SLC8A1 ABCB11 CDH2 CDH3 CDH4 CDH15 | 3.00e-04 | 591 | 295 | 20 | GO:0005911 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KATNAL2 MYO1A EML6 GDPD2 CLASP2 CLIP1 SYNJ2 PKP2 GOLGA2 VCL KIF2C WHRN KIF6 HDAC6 DYNC2H1 DCTN2 CEP162 ARFGEF2 PPL LRPPRC SLC8A1 SLC8A3 AFAP1 INF2 MACF1 ARHGAP18 | 4.54e-04 | 899 | 295 | 26 | GO:0099513 |
| GeneOntologyCellularComponent | desmosome | 6.09e-04 | 28 | 295 | 4 | GO:0030057 | |
| GeneOntologyCellularComponent | microtubule | KATNAL2 EML6 CLASP2 CLIP1 SYNJ2 GOLGA2 KIF2C KIF6 HDAC6 DYNC2H1 DCTN2 CEP162 ARFGEF2 LRPPRC SLC8A1 SLC8A3 MACF1 ARHGAP18 | 6.12e-04 | 533 | 295 | 18 | GO:0005874 |
| GeneOntologyCellularComponent | neuronal cell body | RELN MYO1A MYO10 SYNPO RTN1 ITPR3 CPNE6 KCND3 WASHC5 GOLGA2 WHRN CACNA1C DRD1 HDAC6 AZIN2 HCN1 NR1D1 SLC8A1 SLC8A3 OPTN ASL LRP4 LRP6 WDFY3 | 8.17e-04 | 835 | 295 | 24 | GO:0043025 |
| GeneOntologyCellularComponent | catenin complex | 1.02e-03 | 32 | 295 | 4 | GO:0016342 | |
| GeneOntologyCellularComponent | somatodendritic compartment | GABRG3 ARHGAP32 RELN MYO1A MYO10 SYNPO RTN1 KLHL20 STAT1 ITPR3 CPNE6 KCND3 WASHC5 HRH1 GOLGA2 WHRN CACNA1C DRD1 HDAC6 GIT1 AZIN2 HCN1 ARFGEF2 NR1D1 SLC8A1 SLC8A3 OPTN ASL LRP4 LRP6 WDFY3 | 1.26e-03 | 1228 | 295 | 31 | GO:0036477 |
| Domain | CBX7_C | 3.81e-05 | 5 | 295 | 3 | IPR033773 | |
| Domain | CBX7_C | 3.81e-05 | 5 | 295 | 3 | PF17218 | |
| Domain | Cadherin_C | 3.90e-05 | 25 | 295 | 5 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 3.90e-05 | 25 | 295 | 5 | IPR000233 | |
| Domain | Cadherin_CS | 5.81e-05 | 109 | 295 | 9 | IPR020894 | |
| Domain | CADHERIN_1 | 7.70e-05 | 113 | 295 | 9 | PS00232 | |
| Domain | Cadherin | 7.70e-05 | 113 | 295 | 9 | PF00028 | |
| Domain | - | 8.24e-05 | 114 | 295 | 9 | 2.60.40.60 | |
| Domain | CADHERIN_2 | 8.24e-05 | 114 | 295 | 9 | PS50268 | |
| Domain | Catenin_binding_dom | 8.27e-05 | 29 | 295 | 5 | IPR027397 | |
| Domain | - | 8.27e-05 | 29 | 295 | 5 | 4.10.900.10 | |
| Domain | CA | 8.82e-05 | 115 | 295 | 9 | SM00112 | |
| Domain | Cadherin-like | 9.43e-05 | 116 | 295 | 9 | IPR015919 | |
| Domain | Cadherin | 1.08e-04 | 118 | 295 | 9 | IPR002126 | |
| Domain | Chromodomain_CS | 1.57e-04 | 18 | 295 | 4 | IPR023779 | |
| Domain | Cadherin_pro | 2.06e-04 | 8 | 295 | 3 | SM01055 | |
| Domain | Calx_beta | 2.06e-04 | 8 | 295 | 3 | SM00237 | |
| Domain | Cadherin_pro_dom | 2.06e-04 | 8 | 295 | 3 | IPR014868 | |
| Domain | DUOX1 | 2.49e-04 | 2 | 295 | 2 | IPR029595 | |
| Domain | Calx_beta | 3.05e-04 | 9 | 295 | 3 | IPR003644 | |
| Domain | Calx-beta | 3.05e-04 | 9 | 295 | 3 | PF03160 | |
| Domain | HGTP_anticodon | 3.05e-04 | 9 | 295 | 3 | PF03129 | |
| Domain | Metal_Hydrolase | 5.05e-04 | 24 | 295 | 4 | IPR032466 | |
| Domain | Chromo_domain | 5.05e-04 | 24 | 295 | 4 | IPR023780 | |
| Domain | aa-tRNA-synt_IIb | 5.86e-04 | 11 | 295 | 3 | IPR002314 | |
| Domain | - | 5.86e-04 | 11 | 295 | 3 | 3.40.50.800 | |
| Domain | tRNA-synt_2b | 5.86e-04 | 11 | 295 | 3 | PF00587 | |
| Domain | Chromo | 6.93e-04 | 26 | 295 | 4 | PF00385 | |
| Domain | Na_Ca_Ex | 7.38e-04 | 3 | 295 | 2 | IPR004836 | |
| Domain | Na_Ca_Ex_C-exten | 7.38e-04 | 3 | 295 | 2 | IPR032452 | |
| Domain | Na_Ca_ex_C | 7.38e-04 | 3 | 295 | 2 | PF16494 | |
| Domain | Ran_BP1 | 7.72e-04 | 12 | 295 | 3 | PF00638 | |
| Domain | RANBD1 | 7.72e-04 | 12 | 295 | 3 | PS50196 | |
| Domain | CHROMO_2 | 9.26e-04 | 28 | 295 | 4 | PS50013 | |
| Domain | CHROMO_1 | 9.26e-04 | 28 | 295 | 4 | PS00598 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CPAMD8 MYCBP2 SRF L2HGDH PEX14 NCAM2 CLASP2 SYNPO COG3 INTS3 PLEKHM1 LRFN2 SYNJ2 KCND3 FBXO42 EIF2B4 TTC12 ZNF638 TAF4 ADGRD1 LRRC41 CACNA1C TSNARE1 ANXA6 FRMPD2 DYNC2I1 ADGRL1 BTAF1 C2CD2 PACS1 LRPPRC FAM111A INF2 LPCAT3 SETBP1 AUTS2 ANKRD17 MACF1 CAMKMT ZNF839 ARHGEF26 VPS13B CDH15 XPO7 | 1.08e-12 | 1489 | 300 | 44 | 28611215 |
| Pubmed | RGPD4 ARHGAP32 ILF3 MYCBP2 SPTBN1 ETF1 CLASP2 SYNPO CLIP1 RTN1 RCOR1 RGPD3 TAF4 GOLGA2 WNK3 PRRC2B KIF2C RANBP10 SIN3B GIT1 ZNF618 HCN1 DPYSL4 LRPPRC ANKRD17 ELAVL1 MACF1 CCAR2 WDFY3 SSH2 PRRT1 ARHGEF26 CDH2 | 2.10e-11 | 963 | 300 | 33 | 28671696 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYCBP2 MYO10 MCM5 CLASP2 BIRC6 PLEKHM1 RYR1 ITPR3 PPP1R26 MTMR3 WDR90 PRRC2B CBX2 DOCK3 PLXNA3 RANBP10 FRAS1 SZT2 POLE TSNARE1 ARFGEF2 ARHGAP17 ADGRL1 BTAF1 LARS2 C2CD2 WDR59 GRAMD2A INF2 CSPG4 LRP4 CENPV SLC7A5 WDFY3 ZNF839 | 4.29e-11 | 1105 | 300 | 35 | 35748872 |
| Pubmed | NUP50 ARHGAP32 MOSPD2 RNGTT ZFYVE16 MYCBP2 SPTBN1 FAM91A1 CLASP2 BIRC6 ITPR3 PHKA1 WASHC5 MTMR3 ZNF638 SNX27 ANKRD52 PRRC2B CBX2 DDX31 CEP162 TTC27 PPP4R3A PACS1 TMF1 LRP6 CCAR2 AATF MPHOSPH9 SSH2 PEAK1 SCIN | 7.85e-10 | 1049 | 300 | 32 | 27880917 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYC UTP6 EPRS1 ILF3 MYCBP2 SPTBN1 GARS1 PSMB3 MCM5 DUS3L BIRC6 STAT1 DNTTIP2 WASHC5 EIF2B4 ZNF638 PKP2 SNX27 TAF2 ANKRD52 VCL KIF2C HDAC6 POLE TTC27 WDR59 TGM1 TGM3 LRPPRC INF2 ANKRD17 ELAVL1 MACF1 CCAR2 AATF WDFY3 | 2.47e-09 | 1353 | 300 | 36 | 29467282 |
| Pubmed | DOCK4 ZFYVE16 MYO10 FAM91A1 CSMD3 LRFN2 MTMR3 SNX27 PRRC2B WHRN FRAS1 HDAC5 ADGRL1 MACF1 PPIP5K1 CCAR2 ASXL2 VPS13B XPO7 | 3.47e-09 | 407 | 300 | 19 | 12693553 | |
| Pubmed | MOSPD2 ATP7B ZFYVE16 EMC8 COG3 RTN1 PLEKHM1 ITPR3 WASHC5 COG4 GOLGA2 PPFIBP1 PIGS ARFGEF2 WDR59 NBAS INF2 LPCAT3 TMF1 SCIN VPS13B | 3.85e-09 | 504 | 300 | 21 | 34432599 | |
| Pubmed | MOSPD2 ATP7B ZFYVE16 MYCBP2 CLASP2 BIRC6 RTN1 PCDH17 CTNNBIP1 SYNJ2 YAP1 AMOTL1 CLPTM1 ZNF638 COG4 VCL DYNC2I1 ARHGAP17 NDFIP2 WDR59 NBAS TMF1 SLC7A5 CCAR2 MPHOSPH9 | 7.06e-09 | 733 | 300 | 25 | 34672954 | |
| Pubmed | EPRS1 ARHGAP32 ILF3 SPTBN1 ETF1 PSMB3 NCAM2 CLASP2 SYNPO RTN1 CPNE6 KCND3 WASHC5 FGA SNX27 VCL PRRC2B GIT1 DCTN2 ARFGEF2 ZC3HC1 DPYSL4 ADGRL1 PACS1 TGM1 LRPPRC TARS3 AFAP1 INF2 VCAN ELAVL1 MACF1 SSH2 PEAK1 CDH2 | 3.44e-08 | 1431 | 300 | 35 | 37142655 | |
| Pubmed | ARHGAP32 CEP128 BIRC6 PHKA1 RCOR1 WASHC5 PRRC2B HDAC5 GIT1 PPFIBP1 POLE NBAS TMF1 MPHOSPH9 | 4.69e-08 | 251 | 300 | 14 | 29778605 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | NUP50 RNGTT MYCBP2 GARS1 CLASP2 CLIP1 RCOR1 YAP1 AMOTL1 CLPTM1 EIF2B4 ZNF638 SNX27 RSPH10B VCL PRRC2B KIF2C WHRN RANBP10 HDAC5 GIT1 DYNC2H1 DCTN2 PPFIBP1 PIGS DYNC2I1 ECHS1 PPP4R3A PACS1 LRPPRC LPCAT3 CCAR2 WDTC1 | 5.35e-08 | 1321 | 300 | 33 | 27173435 |
| Pubmed | EPRS1 ACOT9 L2HGDH FAM91A1 INTS3 WASHC5 ANAPC2 ZNF638 COG4 GOLGA2 PRRC2B LRRC41 FRAS1 ARHGEF28 RBBP5 PPFIBP1 POLE CC2D1B BTAF1 KLHL11 PACS1 ANKRD17 | 6.66e-08 | 650 | 300 | 22 | 38777146 | |
| Pubmed | UTP6 MYCBP2 SPTBN1 MCM5 BIRC6 DNTTIP2 ITPR3 ZNF638 ANKRD52 VCL PRRC2B DDX31 POLE ANXA6 TGM3 LRPPRC ANKRD17 ELAVL1 MACF1 CCAR2 AATF XPO7 | 7.21e-08 | 653 | 300 | 22 | 22586326 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | CYP20A1 FAM91A1 EMC8 PLEKHN1 BIRC6 GRAMD4 SYNJ2 YAP1 CLPTM1 ANAPC2 FGA PPFIBP1 RRM2B AGPAT1 BTAF1 C2CD2 LPCAT3 TMF1 LRP4 MACF1 SLC7A5 PEAK1 CDH2 | 9.15e-08 | 719 | 300 | 23 | 35337019 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RGPD4 NUP50 ILF3 STAG1 ACOT9 GARS1 CLASP2 CLIP1 RCOR1 SYNJ2 WASHC5 RGPD3 ANAPC2 FGA GOLGA2 VCL PRRC2B HDAC6 DCTN2 TTC27 DYNC2I1 PPL PACS1 NBAS TGM1 INF2 CCAR2 ASXL2 VPS13B WDTC1 | 9.80e-08 | 1155 | 300 | 30 | 20360068 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | NUP50 SPTBN1 GARS1 ETF1 PSMB3 PEX14 MCM5 SYNPO INTS3 STAT1 WASHC5 CLPTM1 HDGFL2 VCL PRRC2B KIF2C SIN3B HDAC6 DCTN2 RRM2B ANXA6 DPYSL4 ECHS1 PPL TGM1 TGM3 LRPPRC OPTN INF2 ANKRD17 SLC7A5 AATF XPO7 | 1.18e-07 | 1367 | 300 | 33 | 32687490 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | UTP6 NUP50 CNNM2 RNGTT ZFYVE16 PSMB3 MCM5 FN3K ITPR3 RCOR1 YAP1 EIF2B4 MTMR3 SNX27 ANKRD52 VCL PRRC2B KIF2C RANBP10 POLE TTC27 PPL PPP4R3A LRPPRC ANKRD17 CCAR2 ATP2A1 | 1.24e-07 | 974 | 300 | 27 | 28675297 |
| Pubmed | EPRS1 MOSPD2 ILF3 ATP7B MYCBP2 CYP20A1 PEX14 MCM5 CLASP2 EMC8 APOBR BIRC6 ITPR3 CLPTM1 LRRC41 KIF2C GIT1 PIGS ANXA6 AGPAT1 ARFGEF2 NBAS LRPPRC LPCAT3 ANKRD17 ELAVL1 SLC7A5 MPHOSPH9 ARHGAP45 ADPGK | 1.25e-07 | 1168 | 300 | 30 | 19946888 | |
| Pubmed | RGPD4 EFCAB5 EPRS1 EME1 ILF3 MYO1A STAG1 SPTBN1 GARS1 EML6 BAG1 MCM5 SYNPO EMC8 DCC CEP128 DNTTIP2 RGPD3 TAF4 HDGFL2 PRRC2B PLXNA3 CACNA1C DUOX2 CC2D1B PPL LRPPRC MYPOP CSPG4 MACF1 SLC7A5 CCAR2 AATF ATP2A1 | 1.30e-07 | 1442 | 300 | 34 | 35575683 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MYC UTP6 MYO1A STAG1 IRF3 INTS3 STAT1 FBXO42 ANKRD52 LRRC41 KIF2C SIN3B HDAC6 HDAC5 RBBP5 POLE FBXO11 BTAF1 PPARG TGM1 TMF1 ANKRD17 CCAR2 ASXL2 XPO7 | 1.43e-07 | 857 | 300 | 25 | 25609649 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | EPRS1 ILF3 MYCBP2 ACOT9 SPTBN1 GARS1 ETF1 PSMB3 COG3 RYR1 ADK DUOX1 VCL DYNC2H1 ECHS1 NBAS LRPPRC ELAVL1 MACF1 PEAK1 ARHGAP18 MYO15A ATP2A1 MYO16 | 1.82e-07 | 807 | 300 | 24 | 30575818 |
| Pubmed | ARHGAP32 PPP1R26 SYNJ2 WHRN RANBP10 RBM12 LRP4 MACF1 MYO16 WDTC1 | 2.10e-07 | 130 | 300 | 10 | 12421765 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | EPRS1 EME1 ILF3 MYCBP2 SPTBN1 TATDN2 FAM91A1 INTS3 CLIP1 YAP1 ZNF638 UNC5D HDAC6 GIT1 ARFGEF2 BTAF1 NR1D1 PPL PPP4R3A PACS1 ANKRD17 SLC7A5 CCAR2 | 3.34e-07 | 774 | 300 | 23 | 15302935 |
| Pubmed | ARHGAP32 BIRC6 PPP1R26 FBXO42 DOCK3 RANBP10 SIN3B ARHGEF28 DYNC2H1 ZNF618 PPFIBP1 CC2D1B WDR59 PPP4R3A MACF1 SSH2 PEAK1 SCIN | 3.60e-07 | 493 | 300 | 18 | 15368895 | |
| Pubmed | MYBPH MYCBP2 SPTBN1 CLASP2 BTBD1 BIRC6 CLIP1 DNTTIP2 RYR1 VCL GIT1 RBBP5 LRPPRC OPTN XIRP2 MACF1 ATP2A1 ADPGK | 4.05e-07 | 497 | 300 | 18 | 23414517 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DOCK4 ARHGAP32 MYCBP2 SPTBN1 CLASP2 SYNJ2 YAP1 PKP2 WNK3 KIF2C ARHGEF28 GIT1 CEP162 PPFIBP1 ARHGAP17 WDR59 LRPPRC OPTN OTUD7A ANKRD17 MACF1 MPHOSPH9 SSH2 PEAK1 | 5.79e-07 | 861 | 300 | 24 | 36931259 |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 8.58e-07 | 38 | 300 | 6 | 30786075 | |
| Pubmed | MYC ARHGAP32 SPTBN1 SYNPO STAT1 SYNJ2 ZBTB18 COG4 GOLGA2 DCTN2 ARHGAP17 ADGRL1 PPP4R3A ANKRD17 MACF1 MPHOSPH9 ZNF839 | 1.37e-06 | 486 | 300 | 17 | 20936779 | |
| Pubmed | ARHGAP32 MYO1A MYCBP2 ITPR3 WASHC5 PKP2 RANBP10 ZNF618 ECHS1 LRPPRC ASL PEAK1 ARHGAP45 | 1.56e-06 | 288 | 300 | 13 | 38496616 | |
| Pubmed | 1.71e-06 | 11 | 300 | 4 | 28239148 | ||
| Pubmed | Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CLpro substrate degradome. | 1.83e-06 | 43 | 300 | 6 | 34672947 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | DCHS2 MATN3 SPTBN1 ETF1 L2HGDH CLASP2 FN3K IFIH1 FGA TAF4 HDGFL2 GOLGA2 KIF2C CACNA1C LOXHD1 XIRP2 ERCC6L2 | 1.85e-06 | 497 | 300 | 17 | 36774506 |
| Pubmed | 2.53e-06 | 4 | 300 | 3 | 9015265 | ||
| Pubmed | EPRS1 DCHS2 RELN STAG1 MYCBP2 SPTBN1 NCAM2 SYNPO BTBD1 STAT1 FN3K MTMR3 COG4 DOCK3 HDAC6 GIT1 PPFIBP1 HCN1 RBP4 ARFGEF2 TTC27 DYNC2I1 FBXO11 NR1D1 WDR59 TARS3 LRP4 MACF1 WDFY3 | 2.74e-06 | 1285 | 300 | 29 | 35914814 | |
| Pubmed | EPRS1 SPTBN1 FAM91A1 CLASP2 DUS3L STAT1 DNTTIP2 RCOR1 ALDH1L2 ZNF638 SNX27 COG4 KIF2C HDAC6 CEP162 FBXO11 GRAMD2A PACS1 INF2 VCAN ANKRD17 MACF1 AATF ASXL2 PEAK1 VPS13B | 3.13e-06 | 1084 | 300 | 26 | 11544199 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | ILF3 MYCBP2 FAM91A1 RCOR1 EIF2B4 ZNF638 WNK3 PRRC2B TENT4A FBXO11 PACS1 TARS3 ANKRD17 ELAVL1 CCAR2 XPO7 | 3.19e-06 | 462 | 300 | 16 | 31138677 |
| Pubmed | UTP6 ARHGAP32 INTS3 RYR1 ITPR3 TAF2 ANKRD52 RAB4A PRRC2B LRRC41 DYNC2H1 AZIN2 POLE ANXA6 ANKRD17 CENPV AATF WDFY3 ARHGAP45 | 3.49e-06 | 638 | 300 | 19 | 31182584 | |
| Pubmed | EPRS1 RELN SPTBN1 ITPR3 ZNF638 GOLGA2 PPFIBP1 ARHGAP17 BTAF1 PPL PACS1 OPTN ELAVL1 MACF1 | 3.54e-06 | 360 | 300 | 14 | 33111431 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | NUP50 EPRS1 SPTBN1 GARS1 ETF1 PSMB3 BAG1 MCM5 COG3 DUS3L BIRC6 CLIP1 STAT1 WASHC5 YAP1 HDGFL2 VCL GIT1 DCTN2 ANXA6 ARFGEF2 ZC3HC1 CC2D1B ECHS1 PPP4R3A OPTN RBM12 ASL MACF1 CCAR2 XPO7 | 3.94e-06 | 1455 | 300 | 31 | 22863883 |
| Pubmed | EPRS1 ARHGAP32 ILF3 ZFYVE16 SPTBN1 ETF1 STAT1 PKP2 VCL KIF2C HDAC6 PPFIBP1 CC2D1B LRPPRC LRP6 ANKRD17 MACF1 MPHOSPH9 PEAK1 ARHGEF26 | 4.25e-06 | 708 | 300 | 20 | 39231216 | |
| Pubmed | RNGTT PEX14 FAM91A1 CLASP2 BIRC6 AMOTL1 EIF2B4 ZNF638 PKP2 PRRC2B CEP162 PPFIBP1 ARFGEF2 ZC3HC1 PPL TMF1 SLC7A5 CCAR2 MPHOSPH9 PEAK1 XPO7 | 4.81e-06 | 777 | 300 | 21 | 35844135 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | UTP6 EPRS1 ILF3 ACOT9 SPTBN1 GARS1 ETF1 MCM5 SYNPO DNTTIP2 ITPR3 AMOTL1 EIF2B4 ZNF638 PKP2 GOLGA2 KIF2C DSG3 PPFIBP1 PPL TGM3 LRPPRC AFAP1 ANKRD17 CENPV ELAVL1 SLC7A5 AATF | 5.23e-06 | 1257 | 300 | 28 | 36526897 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | DOCK4 ARHGAP32 ACOT9 FAM91A1 MCM5 CEP128 CLIP1 SYNJ2 WASHC5 TAF2 ANKRD52 VCL PRRC2B GIT1 DCTN2 CEP162 PPFIBP1 ANXA6 DYNC2I1 DPYSL4 TGM3 MPHOSPH9 | 5.98e-06 | 853 | 300 | 22 | 28718761 |
| Pubmed | MOSPD2 ILF3 MYCBP2 SPTBN1 BAG1 CLASP2 EMC8 DNTTIP2 ITPR3 CLPTM1 EIF2B4 ANKRD52 HDGFL2 VCL LRRC41 FRAS1 DDX31 DYNC2H1 DCTN2 PPFIBP1 POLE ECHS1 NBAS LRPPRC INF2 CENPV MACF1 SLC7A5 PEAK1 VPS13B FAM177A1 | 6.08e-06 | 1487 | 300 | 31 | 33957083 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | NUP50 EPRS1 ILF3 TATDN2 POLE DYNC2I1 LARS2 LRPPRC ELAVL1 AATF WDTC1 | 6.27e-06 | 232 | 300 | 11 | 25515538 |
| Pubmed | 6.27e-06 | 5 | 300 | 3 | 19398467 | ||
| Pubmed | Role of CLASP2 in microtubule stabilization and the regulation of persistent motility. | 6.27e-06 | 5 | 300 | 3 | 17113391 | |
| Pubmed | 6.27e-06 | 5 | 300 | 3 | 22355118 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | MOSPD2 ATP7B L2HGDH CLASP2 EMC8 COG3 CLIP1 FGA SNX27 TAF4 DYNC2H1 PIGS ANXA6 DOLK ARFGEF2 TTC27 NDFIP2 BTAF1 C2CD2 LPCAT3 TMF1 MACF1 CCAR2 WDFY3 ADPGK | 6.61e-06 | 1061 | 300 | 25 | 33845483 |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | MYC MYCBP2 PSMB3 RCOR1 FBXO42 CBX2 SIN3B GIT1 RBBP5 DCTN2 FBXO11 TGM3 CBX6 CBX7 AUTS2 ASXL2 | 7.59e-06 | 495 | 300 | 16 | 27705803 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYO1A MYCBP2 MYO10 ETF1 PSMB3 MCM5 CLASP2 BTBD1 KLHL20 YAP1 AMOTL1 SNX27 ANKRD52 PRRC2B DYNC2H1 FBXO11 WDR59 TGM3 LRPPRC OPTN ANKRD17 ASXL2 MPHOSPH9 WDTC1 | 8.15e-06 | 1005 | 300 | 24 | 19615732 |
| Pubmed | Cadherin expression in the developing mouse olfactory system. | 9.10e-06 | 16 | 300 | 4 | 17278136 | |
| Pubmed | A unique role of cohesin-SA1 in gene regulation and development. | 9.10e-06 | 16 | 300 | 4 | 22415368 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | UTP6 NUP50 STAG1 MYCBP2 DNTTIP2 RCOR1 CDYL SIN3B HDAC6 HDAC5 TTC27 CCAR2 | 9.19e-06 | 289 | 300 | 12 | 23752268 |
| Pubmed | DOCK4 EPRS1 ACOT9 L2HGDH EMC8 BIRC6 STAT1 PHKA1 ALDH1L2 CLPTM1 GOLGA2 PIGS DOLK ARHGAP17 LARS2 NBAS LRPPRC TARS3 ADPGK | 9.75e-06 | 686 | 300 | 19 | 28380382 | |
| Pubmed | DOCK4 NUP50 PSMB3 SYNPO STAT1 PPP1R26 RCOR1 AMOTL1 TAF2 TAF4 PRRC2B CBX2 HDAC6 DCTN2 PPFIBP1 FAM111A INF2 ASXL2 SSH2 | 1.04e-05 | 689 | 300 | 19 | 36543142 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | NUP50 CNNM2 ATP7B MYCBP2 ACOT9 GARS1 PEX14 CEP128 MTMR3 PKP2 GOLGA2 PRRC2B LRRC41 RANBP10 PPFIBP1 PIGS TTC27 WDR59 AATF WDTC1 | 1.07e-05 | 754 | 300 | 20 | 33060197 |
| Pubmed | RGPD4 EPRS1 ILF3 MYCBP2 NPC1L1 ZNF638 LRPPRC LRP6 SLC7A5 ATP2A1 | 1.14e-05 | 202 | 300 | 10 | 24639526 | |
| Pubmed | 1.25e-05 | 6 | 300 | 3 | 1427864 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | RGPD4 EPRS1 MYO1A SPTBN1 GARS1 PSMB3 SORCS1 CLPTM1 EIF2B4 SNX27 VCL DCTN2 TTC27 TGM3 LRPPRC CCAR2 ATP2A1 CDH3 | 1.58e-05 | 647 | 300 | 18 | 26618866 |
| Pubmed | STAG1 ZFYVE16 MYCBP2 SPTBN1 SVEP1 PPP1R26 ANAPC2 PKP2 VCL FLT4 ZSCAN4 ARFGEF2 PPL OPTN CSPG4 MACF1 ASXL2 | 1.78e-05 | 591 | 300 | 17 | 15231748 | |
| Pubmed | RGPD4 ZFYVE16 MYCBP2 SOX8 BIRC6 RCOR1 RGPD3 ANKRD52 SIN3B HDAC5 ZSCAN4 TTC27 TMF1 ANKRD17 | 1.91e-05 | 418 | 300 | 14 | 34709266 | |
| Pubmed | 2.17e-05 | 7 | 300 | 3 | 18354215 | ||
| Pubmed | Genetic dissection of cadherin function during nephrogenesis. | 2.17e-05 | 7 | 300 | 3 | 11839813 | |
| Pubmed | RGPD4 DOCK4 EPRS1 ARHGAP32 MYCBP2 ACOT9 SPTBN1 FAM91A1 SYNPO EMC8 BIRC6 RTN1 KCND3 WASHC5 RGPD3 DOCK3 GIT1 HCN1 ADGRL1 ECHS1 LRPPRC MACF1 SLC7A5 PEAK1 FAM177A1 | 2.17e-05 | 1139 | 300 | 25 | 36417873 | |
| Pubmed | E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. | 2.36e-05 | 20 | 300 | 4 | 7806582 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NUP50 EPRS1 ILF3 ZFYVE16 ETF1 PSMB3 PEX14 RTN1 STAT1 DNTTIP2 ZNF638 HDGFL2 VCL PRRC2B SIN3B DPYSL4 BTAF1 PPP4R3A RBM12 ANKRD17 MACF1 SCIN | 2.41e-05 | 934 | 300 | 22 | 33916271 |
| Pubmed | 2.85e-05 | 101 | 300 | 7 | 9872452 | ||
| Pubmed | DCHS2 ILF3 MYO10 DCC LRFN2 PKP2 SRL MAFB WHRN KIF6 DRD1 WDR59 SLC8A1 TMEM132D AUTS2 AATF MYO15A CDH2 CDH4 MYO16 | 3.16e-05 | 814 | 300 | 20 | 23251661 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ILF3 RNGTT MYCBP2 MCM5 DNTTIP2 ITPR3 PKP2 DDX31 GIT1 RBBP5 RRM2B PPP4R3A ANKRD17 AATF | 3.34e-05 | 440 | 300 | 14 | 34244565 |
| Pubmed | 3.45e-05 | 8 | 300 | 3 | 11784029 | ||
| Pubmed | Recognition and specificity determinants of the human cbx chromodomains. | 3.45e-05 | 8 | 300 | 3 | 21047797 | |
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 3.45e-05 | 8 | 300 | 3 | 19033399 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ARHGAP32 PAG1 ZFYVE16 SPTBN1 FAM91A1 STAT1 SYNJ2 YAP1 PKP2 GOLGA2 VCL PPFIBP1 PPL MACF1 PEAK1 ARHGAP18 | 3.79e-05 | 565 | 300 | 16 | 25468996 |
| Pubmed | CLASP2 BIRC6 CLIP1 YAP1 AMOTL1 MTMR3 PKP2 ANKRD52 KIF2C HDAC6 HDAC5 CEP162 PPFIBP1 MPHOSPH9 | 3.87e-05 | 446 | 300 | 14 | 24255178 | |
| Pubmed | MOSPD2 SPTBN1 PEX14 FAM91A1 EMC8 STAT1 ITPR3 RGPD3 GOLGA2 PPFIBP1 C2CD2 NBAS INF2 TMF1 SLC7A5 VPS13B | 4.04e-05 | 568 | 300 | 16 | 37774976 | |
| Pubmed | 5.14e-05 | 9 | 300 | 3 | 18927235 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | ILF3 STAG1 SPTBN1 MCM5 INTS3 ANAPC2 ZNF638 KIF2C RBBP5 DCTN2 POLE ARFGEF2 ZC3HC1 BTAF1 ELAVL1 MACF1 | 5.38e-05 | 582 | 300 | 16 | 20467437 |
| Pubmed | CNNM2 SPTBN1 NCAM2 DCC FN3K KCND3 HCN1 AGPAT1 ADGRL1 SLC8A1 TMEM132D SLC7A5 PRRT1 | 5.82e-05 | 405 | 300 | 13 | 38187761 | |
| Pubmed | SPTBN1 PSMB3 L2HGDH PEX14 MCM5 SYNPO COG3 ITPR3 EIF2B4 COG4 PRRC2B RANBP10 RBBP5 DCTN2 PPFIBP1 PIGS ANXA6 TTC27 BTAF1 NBAS LRPPRC OPTN AFAP1 INF2 LRP4 ELAVL1 SLC7A5 CCAR2 | 5.94e-05 | 1440 | 300 | 28 | 30833792 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | DOCK4 RNGTT YAP1 FBXO42 ANKRD52 GOLGA2 PRRC2B KIF2C DDX31 HDAC5 GIT1 DYNC2H1 ARHGAP17 PPP4R3A MACF1 SCIN | 6.07e-05 | 588 | 300 | 16 | 38580884 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | MYC NUP50 EPRS1 EME1 ILF3 INTS3 DNTTIP2 ITPR3 RCOR1 YAP1 RGPD3 ANAPC2 ZNF638 CDYL TAF4 HDGFL2 KIF2C SIN3B RBBP5 FBXO11 MYPOP CENPV ELAVL1 SLC7A5 AATF ASXL2 | 6.48e-05 | 1294 | 300 | 26 | 30804502 |
| Pubmed | SYNPO GRAMD4 SYNJ2 WASHC5 ANAPC2 WDR90 SZT2 CEP162 DOLK AFAP1 RBM12 SETBP1 AUTS2 LRP4 ANKRD17 | 6.51e-05 | 529 | 300 | 15 | 14621295 | |
| Pubmed | 7.03e-05 | 157 | 300 | 8 | 30186101 | ||
| Pubmed | 7.29e-05 | 10 | 300 | 3 | 16537902 | ||
| Pubmed | 7.29e-05 | 10 | 300 | 3 | 23001180 | ||
| Pubmed | ACF7 regulates cytoskeletal-focal adhesion dynamics and migration and has ATPase activity. | 7.29e-05 | 10 | 300 | 3 | 18854161 | |
| Pubmed | 7.42e-05 | 2 | 300 | 2 | 17900358 | ||
| Pubmed | Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism. | 7.42e-05 | 2 | 300 | 2 | 28633507 | |
| Pubmed | 7.42e-05 | 2 | 300 | 2 | 38771357 | ||
| Pubmed | 7.42e-05 | 2 | 300 | 2 | 8247017 | ||
| Pubmed | Identification and analysis of chromodomain-containing proteins encoded in the mouse transcriptome. | 7.42e-05 | 2 | 300 | 2 | 12819141 | |
| Pubmed | c-Myc is crucial for the expression of LAT1 in MIA Paca-2 human pancreatic cancer cells. | 7.42e-05 | 2 | 300 | 2 | 22736142 | |
| Pubmed | 7.42e-05 | 2 | 300 | 2 | 35703534 | ||
| Pubmed | HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease. | 7.42e-05 | 2 | 300 | 2 | 29415205 | |
| Pubmed | The organization of the human gene NCX1 encoding the sodium-calcium exchanger. | 7.42e-05 | 2 | 300 | 2 | 8921376 | |
| Pubmed | Correspondence: Oncogenic MYC persistently upregulates the molecular clock component REV-ERBα. | 7.42e-05 | 2 | 300 | 2 | 28332504 | |
| Pubmed | Reactive oxygen species regulate the levels of dual oxidase (Duox1-2) in human neuroblastoma cells. | 7.42e-05 | 2 | 300 | 2 | 22523549 | |
| Pubmed | Expression of dual oxidases and secreted cytokines in chronic rhinosinusitis. | 7.42e-05 | 2 | 300 | 2 | 23281318 | |
| Pubmed | Lack of effect from genetic deletion of Hdac6 in a humanized mouse model of CMT2D. | 7.42e-05 | 2 | 300 | 2 | 38551018 | |
| Interaction | CAPZA2 interactions | MYC SPTBN1 SYNPO INTS3 CLIP1 ITPR3 WASHC5 FBXO42 AMOTL1 SNX27 HDAC6 DCTN2 TGM3 LRPPRC AFAP1 INF2 LPCAT3 ELAVL1 MACF1 ASXL2 SSH2 | 1.72e-06 | 430 | 296 | 21 | int:CAPZA2 |
| Interaction | RAB7A interactions | MYC NUP50 MOSPD2 ATP7B ZFYVE16 ACOT9 EMC8 COG3 RTN1 PLEKHM1 ITPR3 RAB4B WASHC5 SNX27 RAB4A COG4 GOLGA2 SZT2 PPFIBP1 PIGS ARFGEF2 WDR59 NBAS LRPPRC OPTN INF2 LPCAT3 TMF1 ELAVL1 SCIN ATP2A1 VPS13B | 2.71e-06 | 886 | 296 | 32 | int:RAB7A |
| Interaction | DYNLL2 interactions | MYC FBXO40 RCOR1 YAP1 FBXO42 AMOTL1 HDAC6 DYNC2H1 DCTN2 PPFIBP1 DYNC2I1 DPPA3 OPTN INF2 MPHOSPH9 | 8.71e-06 | 263 | 296 | 15 | int:DYNLL2 |
| Interaction | H3-4 interactions | MYC NUP50 EPRS1 MCM5 RCOR1 CDYL TAF2 TAF4 RAB4A KIF2C CBX2 DOCK3 SIN3B HDAC5 RBBP5 PPP4R3A CBX6 CBX7 VPS13B WDTC1 | 1.15e-05 | 448 | 296 | 20 | int:H3-4 |
| Interaction | YWHAG interactions | MYC DOCK4 ARHGAP32 MYCBP2 SPTBN1 BAG1 NCAM2 MCM5 CLASP2 SYNPO DNTTIP2 SYNJ2 YAP1 MTMR3 ZNF638 PKP2 SNX27 MAFB VCL KIF2C ARHGEF28 HDAC5 GIT1 CEP162 PPFIBP1 ARHGAP17 PPARG DPPA3 PACS1 OPTN OTUD7A ANKRD17 ELAVL1 MACF1 PPIP5K1 MPHOSPH9 SSH2 PEAK1 | 1.63e-05 | 1248 | 296 | 38 | int:YWHAG |
| Interaction | APC interactions | MYC MYCBP2 SPTBN1 CLASP2 SYNPO DCC CEP128 CLIP1 RCOR1 CTNNBIP1 FBXO42 ANAPC2 PKP2 COG4 GOLGA2 ADGRL1 ANKRD17 MACF1 | 1.98e-05 | 389 | 296 | 18 | int:APC |
| Interaction | GPR17 interactions | STAG1 COG3 INTS3 CLPTM1 EIF2B4 COG4 LRRC41 PPFIBP1 DOLK ARFGEF2 BTAF1 NBAS LPCAT3 WDFY3 XPO7 | 2.07e-05 | 283 | 296 | 15 | int:GPR17 |
| Interaction | DYNLL1 interactions | MYC FBXO40 ILF3 MYO10 CEP128 RCOR1 YAP1 AMOTL1 WDR90 RAB4A HDAC6 DYNC2H1 DCTN2 PPFIBP1 TSNARE1 DYNC2I1 DPPA3 OPTN INF2 PKIB MPHOSPH9 | 2.33e-05 | 510 | 296 | 21 | int:DYNLL1 |
| Interaction | RAN interactions | MYC RGPD4 NUP50 EPRS1 RNGTT MYCBP2 GARS1 BAG1 YAP1 RGPD3 RAB4A RANBP10 HDAC6 HDAC5 GIT1 RBBP5 OPTN ELAVL1 ASXL2 XPO7 | 2.67e-05 | 475 | 296 | 20 | int:RAN |
| Interaction | H3-7 interactions | 3.56e-05 | 137 | 296 | 10 | int:H3-7 | |
| Interaction | YWHAH interactions | DOCK4 ARHGAP32 ILF3 MYCBP2 SPTBN1 BAG1 NCAM2 CLASP2 CEP128 IFIH1 SYNJ2 YAP1 MTMR3 ZNF638 PKP2 WNK3 VCL KIF2C ARHGEF28 HDAC5 GIT1 CEP162 PPFIBP1 ARHGAP17 PACS1 OPTN OTUD7A ANKRD17 ELAVL1 MACF1 CCAR2 MPHOSPH9 SSH2 PEAK1 | 3.62e-05 | 1102 | 296 | 34 | int:YWHAH |
| Interaction | DOCK5 interactions | 3.84e-05 | 111 | 296 | 9 | int:DOCK5 | |
| Interaction | MYO5C interactions | MYC SPTBN1 PEX14 SYNPO ANAPC2 SIN3B DCTN2 CEP162 AFAP1 INF2 ELAVL1 | 4.00e-05 | 168 | 296 | 11 | int:MYO5C |
| Interaction | WHRN interactions | 4.09e-05 | 27 | 296 | 5 | int:WHRN | |
| Interaction | NR3C1 interactions | UTP6 ARHGAP32 BAG1 PEX14 MCM5 INTS3 RYR1 ITPR3 RCOR1 FBXO42 TAF2 ANKRD52 RAB4A PRRC2B LRRC41 DOCK3 HDAC6 DYNC2H1 AZIN2 POLE ANXA6 PPARG LRPPRC TMF1 ANKRD17 CENPV ELAVL1 AATF WDFY3 ARHGAP45 RFPL2 | 4.60e-05 | 974 | 296 | 31 | int:NR3C1 |
| Interaction | GJD3 interactions | MOSPD2 ATP7B ZFYVE16 SPTBN1 FAM91A1 EMC8 COG3 ITPR3 PKP2 COG4 GOLGA2 PPFIBP1 AGPAT1 NBAS INF2 TMF1 SLC7A5 PEAK1 VPS13B | 4.61e-05 | 454 | 296 | 19 | int:GJD3 |
| Interaction | DCTN1 interactions | MYC MYCBP2 SPTBN1 PEX14 IRF3 CLASP2 CLIP1 STAT1 RCOR1 SYNJ2 SNX27 ANKRD52 KIF2C HDAC6 DCTN2 CEP162 CC2D1B PPP4R3A MACF1 MPHOSPH9 | 5.03e-05 | 497 | 296 | 20 | int:DCTN1 |
| Interaction | DSP interactions | MYC EPRS1 ILF3 STAG1 MCM5 CEP128 RYR1 RCOR1 YAP1 FBXO42 PKP2 HDAC6 HDAC5 RBBP5 ZC3HC1 PPARG TGM3 WDTC1 | 5.90e-05 | 423 | 296 | 18 | int:DSP |
| Interaction | CTNNA1 interactions | MYC EPRS1 ARHGAP32 SPTBN1 GARS1 CTNNBIP1 YAP1 PKP2 SNX27 VCL MACF1 PEAK1 CDH2 CDH3 CDH15 XPO7 | 5.97e-05 | 347 | 296 | 16 | int:CTNNA1 |
| Interaction | IRF9 interactions | 6.18e-05 | 47 | 296 | 6 | int:IRF9 | |
| Interaction | SEC16A interactions | MYC ARHGAP32 MYO10 SYNPO RCOR1 YAP1 FBXO42 PKP2 GOLGA2 WNK3 VCL PRRC2B DOCK3 HDAC6 DCTN2 CCAR2 ARHGAP18 ATP2A1 | 6.46e-05 | 426 | 296 | 18 | int:SEC16A |
| Interaction | DSCR9 interactions | 6.49e-05 | 147 | 296 | 10 | int:DSCR9 | |
| Interaction | PLK1 interactions | MYC RGPD4 MYCBP2 PSMB3 MCM5 CEP128 BIRC6 ANAPC2 MTMR3 SNX27 ANKRD52 GOLGA2 KIF2C HDAC6 CEP162 RRM2B DYNC2I1 ZC3HC1 TMF1 WDTC1 | 7.18e-05 | 510 | 296 | 20 | int:PLK1 |
| Interaction | NARS1 interactions | 7.27e-05 | 149 | 296 | 10 | int:NARS1 | |
| Interaction | ELOVL5 interactions | MOSPD2 EMC8 RTN1 ITPR3 COG4 TSNARE1 AGPAT1 ARFGEF2 NBAS INF2 TMF1 LRP6 ELAVL1 SLC7A5 VPS13B WDTC1 | 1.04e-04 | 364 | 296 | 16 | int:ELOVL5 |
| Interaction | RGPD8 interactions | 1.07e-04 | 74 | 296 | 7 | int:RGPD8 | |
| Interaction | JUP interactions | MYC ILF3 STAG1 MCM5 SYNPO CEP128 CTNNBIP1 YAP1 PKP2 VCL HDAC6 DSG3 ZC3HC1 KLHL11 LRPPRC CDH2 CDH3 CDH15 WDTC1 | 1.10e-04 | 485 | 296 | 19 | int:JUP |
| Interaction | GAK interactions | BAG1 PEX14 SYNPO ANAPC2 RAB4A WNK3 PLXNA3 CEP162 AFAP1 INF2 ARHGAP18 | 1.16e-04 | 189 | 296 | 11 | int:GAK |
| Interaction | PPP1R21 interactions | 1.16e-04 | 75 | 296 | 7 | int:PPP1R21 | |
| Interaction | TOP3B interactions | EPRS1 MYCBP2 MYO10 MCM5 CLASP2 BIRC6 PLEKHM1 RYR1 ITPR3 PPP1R26 MTMR3 PKP2 WDR90 PRRC2B CBX2 DOCK3 PLXNA3 RANBP10 FRAS1 SZT2 POLE RRM2B TSNARE1 ARFGEF2 ARHGAP17 ADGRL1 BTAF1 LARS2 C2CD2 WDR59 GRAMD2A INF2 CSPG4 LRP4 ANKRD17 CENPV ELAVL1 SLC7A5 WDFY3 ZNF839 | 1.17e-04 | 1470 | 296 | 40 | int:TOP3B |
| Interaction | AFDN interactions | MYC ARHGAP32 YAP1 AMOTL1 ZNF638 PKP2 SNX27 HDAC6 PPFIBP1 OTUD7A TMF1 MACF1 SLC7A5 MPHOSPH9 PEAK1 | 1.31e-04 | 333 | 296 | 15 | int:AFDN |
| Interaction | RAC3 interactions | MYC ARHGAP32 MOSPD2 ZFYVE16 MYO10 SPTBN1 FAM91A1 EMC8 PCDH17 SYNJ2 PKP2 GIT1 PPFIBP1 NDFIP2 ADGRL1 C2CD2 OTUD7A LRP6 MACF1 SLC7A5 PEAK1 CDH2 | 1.32e-04 | 619 | 296 | 22 | int:RAC3 |
| Interaction | TGM1 interactions | MYC L2HGDH YAP1 SNX27 HCN1 AGPAT1 ZC3HC1 KLHL11 TGM1 TGM3 MYPOP RBM12 | 1.48e-04 | 228 | 296 | 12 | int:TGM1 |
| GeneFamily | CD molecules|Type I classical cadherins | 6.92e-08 | 5 | 198 | 4 | 1185 | |
| GeneFamily | Chromobox family | 6.96e-05 | 8 | 198 | 3 | 976 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 8.74e-04 | 181 | 198 | 8 | 694 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MYC DOCK4 RNGTT STAG1 ZFYVE16 MYCBP2 MYO10 PEX14 CLASP2 CLIP1 KLHL20 RCOR1 SYNJ2 YAP1 MTMR3 ZNF638 CDYL TAF4 ZBTB18 VCL BTAF1 LARS2 C2CD2 NBAS LRPPRC AFAP1 ANKRD17 MACF1 MPHOSPH9 WDFY3 CDH2 VPS13B | 4.21e-09 | 856 | 298 | 32 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN | 4.91e-07 | 84 | 298 | 9 | M13008 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | MYC RGPD4 RNGTT STAG1 ZFYVE16 SOX8 CEP128 DNTTIP2 SORCS1 TTC12 CDYL PRRC2B HDAC5 RRM2B BTAF1 LARS2 ECHS1 PACS1 AFAP1 SETBP1 AUTS2 ANKRD17 MPHOSPH9 WDFY3 SSH2 CDH4 VPS13B XPO7 | 1.41e-05 | 1009 | 298 | 28 | M157 |
| Coexpression | GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN | MYO10 BIRC6 LRFN2 SIN3B DPYS KIF6 GIT1 NXNL2 ELAVL1 MPHOSPH9 WDFY3 | 1.89e-05 | 199 | 298 | 11 | M6264 |
| Coexpression | GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP | KLHL20 ADK SRL WDR90 HDAC6 CC2D1B HELQ PKIB WDFY3 ARHGAP45 FAM177A1 | 1.98e-05 | 200 | 298 | 11 | M6653 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | MYC RNGTT STAG1 MYCBP2 MYO10 CLASP2 CLIP1 RCOR1 YAP1 ZNF638 CDYL TAF4 LARS2 C2CD2 LRPPRC AFAP1 ANKRD17 | 2.79e-05 | 466 | 298 | 17 | M13522 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000 | MYC UTP6 KATNAL2 ILF3 MYO10 MCM5 CLASP2 INTS3 TAF2 TAF4 DPYS SZT2 DYNC2H1 CEP162 PPFIBP1 POLE AGPAT1 ARFGEF2 TTC27 VCAN ERCC6L2 LRP4 ASXL2 MPHOSPH9 CDH2 CDH4 XPO7 | 1.25e-05 | 779 | 294 | 27 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000 |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | GABRG3 RELN DCC CSMD3 RYR1 HCN1 SLC8A3 TMEM132D CD226 SPATA16 CDH4 LIX1 | 2.12e-09 | 171 | 300 | 12 | b2e753e811a7639956994609f73efcdb62d04f82 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN NCAM2 DCC CSMD3 SORCS1 UNC5D FRAS1 SLC8A1 LOXHD1 XIRP2 MYO15A MYO16 | 4.87e-09 | 184 | 300 | 12 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN NCAM2 DCC CSMD3 SORCS1 UNC5D FRAS1 SLC8A1 LOXHD1 XIRP2 MYO15A MYO16 | 4.87e-09 | 184 | 300 | 12 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN NCAM2 DCC CSMD3 SORCS1 UNC5D FRAS1 SLC8A1 LOXHD1 XIRP2 MYO15A MYO16 | 4.87e-09 | 184 | 300 | 12 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | GABRG3 RELN NCAM2 DCC CSMD3 RYR1 HCN1 XIRP2 TMEM132D CDH4 MYO16 | 1.16e-08 | 159 | 300 | 11 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | ARHGAP32 STAG1 CLASP2 BIRC6 ARHGEF28 PACS1 NBAS AUTS2 CAMKMT WDFY3 SSH2 VPS13B | 1.18e-08 | 199 | 300 | 12 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | ZNF627 PAG1 ATP7B MYO10 COL6A5 DCC OLFML2A KIF6 KLHL11 MACF1 PEAK1 | 1.24e-08 | 160 | 300 | 11 | 0293b244c063a62819690bf22bbc2681f8d15252 |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | ZNF627 PAG1 ATP7B MYO10 COL6A5 DCC OLFML2A KIF6 KLHL11 MACF1 PEAK1 | 1.24e-08 | 160 | 300 | 11 | 3eaae86fa08f7651021316f8e5811bf48055591e |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_Chrna6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | RELN SORCS1 CYP7B1 NPR3 PPFIBP1 NXNL2 TGM3 ABCB11 PEAK1 LIX1 | 1.35e-08 | 125 | 300 | 10 | fac8a9bff83abb8976013ff7d2b4ce0b68fbb70a |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.44e-08 | 181 | 300 | 11 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.44e-08 | 181 | 300 | 11 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-07 | 196 | 300 | 11 | 34e79918a448f6c19b87e1b1ce13c012b24be1f8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-07 | 196 | 300 | 11 | 8f82e01ca50aa4cd6149547505b4474a02fad618 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-07 | 160 | 300 | 10 | 0544bc465af208da448858d6e174ff56f2e08a46 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | CSMD3 UNC5D DOCK3 CACNA1C FRAS1 POLE DUOX2 LARS2 TGM3 ABCB11 | 1.58e-07 | 162 | 300 | 10 | bf886e22ff2a20353499004b53f25fb9e6574896 |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 1.68e-07 | 163 | 300 | 10 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.80e-07 | 125 | 300 | 9 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | PAG1 CIB4 COL6A5 ADARB2 UNC5D ADGRD1 CACNA1C CSPG4 SETBP1 THNSL2 | 2.92e-07 | 173 | 300 | 10 | fd6653d6be9ca6ac36798590694efe03cb758c67 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.41e-07 | 185 | 300 | 10 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.41e-07 | 185 | 300 | 10 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | DOCK4 NCAM2 DCC ABCA9 SVEP1 CYP7B1 CACNA1C FRAS1 SETBP1 MACF1 | 5.97e-07 | 187 | 300 | 10 | 92d468dde81125d51daf7abd4703741abe1ab91c |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | DOCK4 MYO10 NCAM2 DCC CSMD3 SVEP1 OLFML2A DPYS FRAS1 DYNC2H1 | 6.58e-07 | 189 | 300 | 10 | 203c80030df08ae112f9ae4043709f455d87ce89 |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | STAG1 SPTBN1 NCAM2 ABCA9 SVEP1 SORCS1 ADGRD1 VCAN SETBP1 SSH2 | 8.36e-07 | 194 | 300 | 10 | 234d1494c114cce77c619708bbcd8d5ce805f19b |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | DOCK4 GABRG3 MYO10 NCAM2 CSMD3 SVEP1 OLFML2A CYP7B1 CACNA1C VCAN | 8.36e-07 | 194 | 300 | 10 | 011e14d9ed1393275f892060e7708ffadcd0767f |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | GABRG3 MYO10 NCAM2 SVEP1 OLFML2A CYP7B1 CACNA1C FRAS1 SETBP1 CDH4 | 8.36e-07 | 194 | 300 | 10 | 35f132cc38ac133be01834ed0946188aa0757eb4 |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.43e-07 | 150 | 300 | 9 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | ZNF627 KATNAL2 MYO10 NCAM2 SULT1C4 PCDH17 WNK3 IMPG2 HELQ ZNF14 | 9.17e-07 | 196 | 300 | 10 | 7e98380d815fbf6254289ace2af37aac6fef51e8 |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | NCAM2 SVEP1 YAP1 CYP7B1 CACNA1C PPFIBP1 AFAP1 VCAN SETBP1 AUTS2 | 9.61e-07 | 197 | 300 | 10 | f1c8936986123a3151140c374fcd62d6705c530b |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | DOCK4 MATN3 COL6A5 DCC SVEP1 SORCS1 DYNC2H1 LRP4 MACF1 MYO16 | 1.01e-06 | 198 | 300 | 10 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | GABRG3 ARHGAP32 EML6 CSMD3 RTN1 CACNA1C HCN1 SYT16 SLC8A1 SETBP1 | 1.01e-06 | 198 | 300 | 10 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | DOCK4 ARHGAP32 STAG1 ADK YAP1 AUTS2 CAMKMT WDFY3 PEAK1 VPS13B | 1.01e-06 | 198 | 300 | 10 | 1996373bdccc55aac347d349bd22f6aad6d0c668 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-06 | 199 | 300 | 10 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | DOCK4 MYO10 COL6A5 SVEP1 DYNC2H1 AFAP1 VCAN MACF1 PEAK1 MYO16 | 1.05e-06 | 199 | 300 | 10 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | DOCK4 MYO10 SPTBN1 NCAM2 COL6A5 SVEP1 OLFML2A FRAS1 MACF1 PEAK1 | 1.05e-06 | 199 | 300 | 10 | 212e89d097753790061310373a1fafba773488b6 |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | DOCK4 MYO10 SPTBN1 NCAM2 COL6A5 SVEP1 OLFML2A FRAS1 MACF1 PEAK1 | 1.05e-06 | 199 | 300 | 10 | 14b676aa289c0578a37be32cec3ea285c79d97cc |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | GABRG3 MYCBP2 EML6 CSMD3 RTN1 UNC5D CACNA1C HCN1 SYT16 SETBP1 | 1.10e-06 | 200 | 300 | 10 | 48d801219bc771d6c7e151dc88ca4c179988de85 |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | DCC CSMD3 ADARB2 SORCS1 SLC8A1 AFAP1 TMEM132D VCAN CSPG4 MYO16 | 1.10e-06 | 200 | 300 | 10 | 961858738ce35db8760c8c2e136f8369bc444ccf |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | DCC CSMD3 ADARB2 SORCS1 SLC8A1 AFAP1 TMEM132D VCAN CSPG4 MYO16 | 1.10e-06 | 200 | 300 | 10 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | DCC CSMD3 ADARB2 SORCS1 SLC8A1 AFAP1 TMEM132D VCAN CSPG4 MYO16 | 1.10e-06 | 200 | 300 | 10 | cc3409518f8b436ea92deb955e81114b3f410ff7 |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | DCC CSMD3 ADARB2 SORCS1 SLC8A1 AFAP1 TMEM132D VCAN CSPG4 MYO16 | 1.10e-06 | 200 | 300 | 10 | c24a3099e3d96d8b72f6d05286bb355d661a0377 |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | DCC CSMD3 ADARB2 SORCS1 SLC8A1 AFAP1 TMEM132D VCAN CSPG4 MYO16 | 1.10e-06 | 200 | 300 | 10 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | DCC CSMD3 ADARB2 SORCS1 SLC8A1 AFAP1 TMEM132D VCAN CSPG4 MYO16 | 1.10e-06 | 200 | 300 | 10 | 310cd53db1c137f6af74e6ae682221d7ac27310c |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.06e-06 | 167 | 300 | 9 | 1adb566f98af0109c8cc6e36033b89651e2c75e7 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.06e-06 | 167 | 300 | 9 | 743df5908c1ceb43b34b240d9f9649f30f4142fa | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-06 | 127 | 300 | 8 | 39fa20a55de3af1a62ab5dfa4877879db3935ac2 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.63e-06 | 172 | 300 | 9 | 7c238a7375341d4647ba7274d93fddfb6fae7ce4 | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.39e-06 | 133 | 300 | 8 | a8abb6b54862123961ae6defbf251ee6e9575258 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | DCHS2 NCAM2 PCDH17 SORCS1 SYNJ2 ARHGEF28 PPFIBP1 OPTN ARHGAP18 | 3.64e-06 | 179 | 300 | 9 | 065a50952e8703fa07767beb6b73a090bf378ca6 |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.99e-06 | 181 | 300 | 9 | 3aa81ac64d0cc9a74fbfa71e2176740548e7cd06 | |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.99e-06 | 181 | 300 | 9 | 997ba1be2824b00d684f2163d0114656ed11fa53 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.99e-06 | 181 | 300 | 9 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | 5'-Adult-Appendix-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.99e-06 | 181 | 300 | 9 | e6b7e8dd5c13cc10ba22f2f5a8c669486f934bdc | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.00e-06 | 136 | 300 | 8 | 186be8e1595608004b8216892cb9c7a7f31fbb4d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | DCHS2 NCAM2 PCDH17 SORCS1 SYNJ2 ARHGEF28 PPFIBP1 OPTN ARHGAP18 | 4.17e-06 | 182 | 300 | 9 | 31efc06d6b073e8e341648207093e5f33c6f9183 |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.15e-06 | 100 | 300 | 7 | 20675fc2ffc5ab63047d38da083b50d470f3db19 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.15e-06 | 100 | 300 | 7 | 1de3895e16f14ff32b901b18ce14d965afaa7e76 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.15e-06 | 100 | 300 | 7 | ff1bdb511700a041a90034d1d30dfc25f51d6c82 | |
| ToppCell | COPD-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 5.20e-06 | 187 | 300 | 9 | 406ecd1dabb3ed8d871aef159f7bd1e383434953 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 5.43e-06 | 188 | 300 | 9 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.81e-06 | 143 | 300 | 8 | 24fd24846fbef049af669a57d42fcc18928d2b27 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.91e-06 | 190 | 300 | 9 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 5.91e-06 | 190 | 300 | 9 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 6.44e-06 | 192 | 300 | 9 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.71e-06 | 193 | 300 | 9 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.71e-06 | 193 | 300 | 9 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.71e-06 | 193 | 300 | 9 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | CTRL-Myeloid-Monocyte_Macrophage|Myeloid / Disease state, Lineage and Cell class | 7.00e-06 | 194 | 300 | 9 | 73459ee062ae1f1a3bb9719dc0b89aae10600e22 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.00e-06 | 194 | 300 | 9 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.00e-06 | 194 | 300 | 9 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 7.30e-06 | 195 | 300 | 9 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.48e-06 | 148 | 300 | 8 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.60e-06 | 196 | 300 | 9 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.92e-06 | 197 | 300 | 9 | c165c6fd12dc649b39e920d8528e2eb65c61956b | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.92e-06 | 197 | 300 | 9 | 41dd312f46a2b983c8d864adeb6970c0ca4a8048 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-PFC-29|World / Primary Cells by Cluster | 7.92e-06 | 197 | 300 | 9 | c5bc0e7eb85642b270efc2ba92b13a736af22052 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-PFC|World / Primary Cells by Cluster | 7.92e-06 | 197 | 300 | 9 | 2c3b0072f8e1e09c77a85c6fc3133d1796932fb2 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.92e-06 | 197 | 300 | 9 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 7.92e-06 | 197 | 300 | 9 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.92e-06 | 197 | 300 | 9 | 7870c0651caefb0ed13d9f9dab43b5f24d6a9efc | |
| ToppCell | Mild-Myeloid-Macrophages-FCN1_high|Mild / Condition, Lineage, Cell class and cell subclass | 8.25e-06 | 198 | 300 | 9 | 17aab4dc3b2cd6eb7dda77dd51bdc20490fcfe19 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 8.25e-06 | 198 | 300 | 9 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.59e-06 | 199 | 300 | 9 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.94e-06 | 200 | 300 | 9 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 8.94e-06 | 200 | 300 | 9 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.94e-06 | 200 | 300 | 9 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-OPC_related|6m / Sample Type, Dataset, Time_group, and Cell type. | 8.94e-06 | 200 | 300 | 9 | ea1e3eeddbc398ac97863120f7aa3f17569ca12a | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.94e-06 | 200 | 300 | 9 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-OPC_related-Oligodendrocyte/OPC|6m / Sample Type, Dataset, Time_group, and Cell type. | 8.94e-06 | 200 | 300 | 9 | 4a57f2f2dc6e2402ac4772b5cd38e033a6f1adee | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 8.94e-06 | 200 | 300 | 9 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.94e-06 | 200 | 300 | 9 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.26e-05 | 159 | 300 | 8 | ded4e3626a62fb6334403b7213b467fb7e8131c3 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.26e-05 | 159 | 300 | 8 | 2f6c60ddff2208a68146f9786143d9aefd528840 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 161 | 300 | 8 | 8741b91a62c9a8ce377ef6533d323b65beb93c63 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 161 | 300 | 8 | 45591addc765760db6029ac19e80573373d1d917 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 161 | 300 | 8 | 9cf1dcf0e7ca9e35c46c094a6b78f98d1f6b9276 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lhx6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.45e-05 | 117 | 300 | 7 | 0602bbad908cb28c5093b74d717da5f2af577943 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.73e-05 | 166 | 300 | 8 | c8fd241088de27c6e741a5dfee3cd770183b6bcb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.96e-05 | 169 | 300 | 8 | a0681317867e31319210a23e56660a53f4529efe | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.05e-05 | 170 | 300 | 8 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.05e-05 | 170 | 300 | 8 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| Drug | Carbarsone [121-59-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A | ILF3 RNGTT CYP20A1 GOLGA2 HDAC6 RBBP5 DYNC2H1 CEP162 DPYSL4 FBXO11 NR1D1 PPP4R3A LRP6 WDTC1 | 2.59e-07 | 192 | 298 | 14 | 4110_DN |
| Disease | urate measurement, bone density | KATNAL2 PEX14 COL6A5 CLASP2 CLIP1 PCDH17 YAP1 FBXO42 PRRC2B KIF6 FRAS1 ZNF618 PPFIBP1 AGPAT1 PPL CAMKMT PEAK1 CDH4 MYO16 | 1.40e-05 | 619 | 290 | 19 | EFO_0003923, EFO_0004531 |
| Disease | cortical thickness | CPAMD8 RELN CNNM2 MYCBP2 SPTBN1 BTBD1 PLEKHM1 STAT1 PCDH17 DUOX1 FBXO42 MTMR3 KIF6 PPFIBP1 PCDHB11 ARFGEF2 ZC3HC1 DPYSL4 PPP4R3A SPATA16 VCAN AUTS2 LRP4 MACF1 SSH2 ARHGAP18 MYO16 | 1.67e-05 | 1113 | 290 | 27 | EFO_0004840 |
| Disease | risk-taking behaviour | GABRG3 RELN STAG1 ETF1 DCC DUS3L BIRC6 LRFN2 CYP7B1 ANKRD52 CACNA1C ZNF618 HCN1 TSNARE1 TTC27 FBXO11 LRPPRC AUTS2 LRP4 CAMKMT ATP2A1 | 2.55e-05 | 764 | 290 | 21 | EFO_0008579 |
| Disease | alcohol consumption measurement | RELN SPTBN1 CYP20A1 DCC CSMD3 BIRC6 FBXO42 TTC12 WDR90 IMPG2 CACNA1C DDX31 ZNF618 FBXO11 C2CD2 DMC1 NBAS LRPPRC SLC8A1 SETBP1 AUTS2 CAMKMT AATF ASXL2 PEAK1 MYO15A CDH4 XPO7 | 4.27e-05 | 1242 | 290 | 28 | EFO_0007878 |
| Disease | C-reactive protein measurement | DOCK4 DCHS2 CETP PEX14 INTS3 PCDH17 LRFN2 KCND3 CLPTM1 EIF2B4 MAFB TAF4 DOCK3 ARHGEF28 TSNARE1 ANXA6 PPL DMC1 PACS1 MYPOP CBX6 SPATA16 ABCB11 MACF1 THNSL2 CDH4 FAM177A1 | 6.61e-05 | 1206 | 290 | 27 | EFO_0004458 |
| Disease | lifestyle measurement | ILF3 PCDH17 LRFN2 DOCK3 TSNARE1 ARFGEF2 PACS1 LRPPRC AUTS2 ATP2A1 | 1.21e-04 | 235 | 290 | 10 | EFO_0010724 |
| Disease | body weight | GABRG3 RELN CNNM2 DCC APOBR CLIP1 LRFN2 KCND3 MTMR3 ZNF638 MAFB CDYL COG4 CACNA1C NPR3 TENT4A DPYSL4 WDR59 SYT16 NBAS HHLA2 ASL SETBP1 AUTS2 CAMKMT ARHGEF26 XPO7 | 1.38e-04 | 1261 | 290 | 27 | EFO_0004338 |
| Disease | cognitive function measurement, self reported educational attainment | MYCBP2 DCC BIRC6 PLEKHM1 PCDH17 ZNF638 TSNARE1 ARFGEF2 BTAF1 PPARG LRPPRC AUTS2 | 2.27e-04 | 355 | 290 | 12 | EFO_0004784, EFO_0008354 |
| Disease | hypothyroidism (implicated_via_orthology) | 2.50e-04 | 13 | 290 | 3 | DOID:1459 (implicated_via_orthology) | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | RELN STAG1 LRFN2 TTC12 MAFB PPARG PACS1 SYT16 SETBP1 AUTS2 MACF1 SSH2 | 2.85e-04 | 364 | 290 | 12 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 |
| Disease | brain small vessel disease (is_implicated_in) | 2.87e-04 | 3 | 290 | 2 | DOID:0112313 (is_implicated_in) | |
| Disease | autosomal dominant intellectual developmental disorder (implicated_via_orthology) | 2.87e-04 | 3 | 290 | 2 | DOID:0060307 (implicated_via_orthology) | |
| Disease | inositol measurement | 3.16e-04 | 14 | 290 | 3 | EFO_0010504 | |
| Disease | Seizures | 3.28e-04 | 218 | 290 | 9 | C0036572 | |
| Disease | cancer (implicated_via_orthology) | 3.47e-04 | 268 | 290 | 10 | DOID:162 (implicated_via_orthology) | |
| Disease | cortical surface area measurement | EFCAB5 DCHS2 CPAMD8 RELN CNNM2 STAG1 MYCBP2 SPTBN1 PLEKHM1 SVEP1 STAT1 FBXO42 ZBTB18 KIF6 RBBP5 CEP162 PPFIBP1 PPP4R3A AFAP1 SPATA16 VCAN AUTS2 MACF1 MPHOSPH9 SSH2 PRRT1 MYO16 | 3.81e-04 | 1345 | 290 | 27 | EFO_0010736 |
| Disease | uric acid measurement | CNNM2 EFCAB13 BIRC6 DUS2 ANKRD52 PRRC2B FRAS1 FLT4 DYNC2H1 TTC27 ARHGAP17 PPARG PACS1 SETBP1 ASXL2 ARHGEF26 | 3.94e-04 | 610 | 290 | 16 | EFO_0004761 |
| Disease | smoking cessation | CNNM2 STAG1 DCC CSMD3 BIRC6 ITPR3 TTC12 HCN1 HHLA2 AUTS2 CAMKMT | 4.07e-04 | 325 | 290 | 11 | EFO_0004319 |
| Disease | Malignant neoplasm of breast | ATP7B EFCAB13 BAG1 COG3 CLIP1 STAT1 SORCS1 SYNJ2 YAP1 MTMR3 KIF6 DYNC2H1 PIGS PCDHB15 ARFGEF2 HELQ SLC8A3 ASL SETBP1 MACF1 PRRT1 CDH2 VPS13B | 4.32e-04 | 1074 | 290 | 23 | C0006142 |
| Disease | Colorectal Neoplasms | 4.50e-04 | 277 | 290 | 10 | C0009404 | |
| Disease | ureidopropionic acid measurement | 4.79e-04 | 16 | 290 | 3 | EFO_0010542 | |
| Disease | biological sex | 4.84e-04 | 230 | 290 | 9 | PATO_0000047 | |
| Disease | longevity | UTP6 NCAM2 DCC SVEP1 ADGRD1 ARFGEF2 ECHS1 SYT16 SPATA16 CDH4 | 5.46e-04 | 284 | 290 | 10 | EFO_0004300 |
| Disease | Afibrinogenemia | 5.70e-04 | 4 | 290 | 2 | C0001733 | |
| Disease | phenylketonuria (implicated_via_orthology) | 5.70e-04 | 4 | 290 | 2 | DOID:9281 (implicated_via_orthology) | |
| Disease | Triple Negative Breast Neoplasms | 5.70e-04 | 4 | 290 | 2 | C3539878 | |
| Disease | Congenital hypofibrinogenemia | 5.70e-04 | 4 | 290 | 2 | C2584774 | |
| Disease | Manic Disorder | 6.79e-04 | 71 | 290 | 5 | C0024713 | |
| Disease | food allergy measurement, parental genotype effect measurement | 6.87e-04 | 18 | 290 | 3 | EFO_0005939, EFO_0007016 | |
| Disease | venous thromboembolism | DCHS2 RELN NCAM2 ITPR3 OLFML2A CTNNBIP1 FGA CYP7B1 ARHGEF28 WDR59 OTUD7A LRP4 MPHOSPH9 | 6.92e-04 | 460 | 290 | 13 | EFO_0004286 |
| Disease | Alzheimer disease, educational attainment | 8.05e-04 | 247 | 290 | 9 | EFO_0011015, MONDO_0004975 | |
| Disease | testosterone measurement | DOCK4 DCHS2 STAG1 ETF1 NME9 CSMD3 BIRC6 YAP1 EIF2B4 MAFB TAF4 UNC5D DOCK3 TTC27 ZC3HC1 FBXO11 PPARG C2CD2 MYPOP AUTS2 MACF1 PRRT1 MYO15A ATP2A1 MYO16 | 8.76e-04 | 1275 | 290 | 25 | EFO_0004908 |
| Disease | Fibrinogen Deficiency | 9.44e-04 | 5 | 290 | 2 | C4316812 | |
| Disease | Vitamin A Deficiency | 9.44e-04 | 5 | 290 | 2 | C0042842 | |
| Disease | cholangiocarcinoma, sclerosing cholangitis | 9.44e-04 | 5 | 290 | 2 | EFO_0004268, EFO_0005221 | |
| Disease | Short rib-polydactyly syndrome, Verma-Naumoff type | 9.44e-04 | 5 | 290 | 2 | C0432197 | |
| Disease | Alzheimer disease, whole-brain volume | 9.44e-04 | 5 | 290 | 2 | EFO_0005089, MONDO_0004975 | |
| Disease | psoriasis, coronary artery disease | 9.44e-04 | 5 | 290 | 2 | EFO_0000676, EFO_0001645 | |
| Disease | Duane Retraction Syndrome | 9.44e-04 | 5 | 290 | 2 | C0013261 | |
| Disease | temporal lobe epilepsy (is_marker_for) | 9.46e-04 | 20 | 290 | 3 | DOID:3328 (is_marker_for) | |
| Disease | Manic | 1.04e-03 | 78 | 290 | 5 | C0338831 | |
| Disease | Depression, Bipolar | 1.10e-03 | 79 | 290 | 5 | C0005587 | |
| Disease | Abnormality of refraction | GABRG3 ARHGAP32 CIART PEX14 BIRC6 MTMR3 FRMPD2B DOCK3 HCN1 FRMPD2 SLC8A1 AUTS2 CCAR2 CAMKMT PEAK1 CDH2 | 1.12e-03 | 673 | 290 | 16 | HP_0000539 |
| Disease | alkaline phosphatase measurement | CNNM2 SPTBN1 CYP20A1 PLEKHM1 DUS2 RAB4B SYNJ2 YAP1 CLPTM1 EIF2B4 MAFB COG4 FAM118B WHRN PPARG PPL ZNF14 ASL ABCB11 MACF1 THNSL2 | 1.17e-03 | 1015 | 290 | 21 | EFO_0004533 |
| Disease | body fat percentage | RELN STAG1 LRFN2 TTC12 MAFB PRRC2B PPARG PACS1 SYT16 SETBP1 AUTS2 MACF1 SSH2 | 1.18e-03 | 488 | 290 | 13 | EFO_0007800 |
| Disease | hair colour measurement | GABRG3 ILF3 ZFYVE16 L2HGDH PEX14 NME9 MAFB FRAS1 ZNF618 SETBP1 SLC7A5 ASXL2 THNSL2 ARHGEF26 CDH15 | 1.23e-03 | 615 | 290 | 15 | EFO_0007822 |
| Disease | schizophrenia, anorexia nervosa | 1.27e-03 | 48 | 290 | 4 | MONDO_0005090, MONDO_0005351 | |
| Disease | Disease Exacerbation | 1.28e-03 | 165 | 290 | 7 | C0235874 | |
| Disease | irritability measurement | 1.30e-03 | 82 | 290 | 5 | EFO_0009594 | |
| Disease | cigarettes per day measurement | PAG1 STAG1 CIART NME9 DCC DUS3L PCDH17 RAB4B UNC5D ZNF618 BTAF1 AUTS2 | 1.43e-03 | 438 | 290 | 12 | EFO_0006525 |
| Disease | glucose measurement | MYCBP2 EFCAB13 EML6 BAG1 ITPR3 EIF2B4 MTMR3 SRL SLC8A1 AUTS2 ABCB11 | 1.45e-03 | 380 | 290 | 11 | EFO_0004468 |
| Disease | disease recurrence, colon carcinoma | 1.59e-03 | 51 | 290 | 4 | EFO_0004952, EFO_1001950 | |
| Disease | Brugada Syndrome (disorder) | 1.63e-03 | 24 | 290 | 3 | C1142166 | |
| Disease | Dyslipidemias | 1.63e-03 | 24 | 290 | 3 | C0242339 | |
| Disease | Dyslipoproteinemias | 1.63e-03 | 24 | 290 | 3 | C0598784 | |
| Disease | mortality | 1.68e-03 | 173 | 290 | 7 | EFO_0004352 | |
| Disease | Intellectual Disability | STAG1 ACOT9 L2HGDH DCC ADK SNX27 TAF2 RRM2B PACS1 SETBP1 MACF1 CDH2 | 1.70e-03 | 447 | 290 | 12 | C3714756 |
| Disease | Colorectal Carcinoma | MYC CPAMD8 ATP7B DCC CSMD3 ADARB2 ABCA9 KCND3 YAP1 HRH1 POLE FRMPD2 PPARG CD226 SETBP1 ABCB11 | 1.72e-03 | 702 | 290 | 16 | C0009402 |
| Disease | unipolar depression, schizophrenia | 1.84e-03 | 25 | 290 | 3 | EFO_0003761, MONDO_0005090 | |
| Disease | Cardiac Arrhythmia | 1.84e-03 | 25 | 290 | 3 | C0003811 | |
| Disease | Polycystic kidney disease, type 2 | 1.96e-03 | 7 | 290 | 2 | C2751306 | |
| Disease | phosphatidylcholine measurement | 2.11e-03 | 284 | 290 | 9 | EFO_0010226 | |
| Disease | FEV/FEC ratio | UTP6 EFCAB5 DCHS2 CIB4 PSMB3 DCC ADK RAB4B MTMR3 MAFB FRAS1 ARHGEF28 RBBP5 HCN1 PPARG SLC8A1 AFAP1 CSPG4 ERCC6L2 SSH2 MYO15A ARHGEF26 MYO16 | 2.51e-03 | 1228 | 290 | 23 | EFO_0004713 |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 2.57e-03 | 28 | 290 | 3 | DOID:1094 (implicated_via_orthology) | |
| Disease | Profound Mental Retardation | 2.58e-03 | 139 | 290 | 6 | C0020796 | |
| Disease | Mental deficiency | 2.58e-03 | 139 | 290 | 6 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 2.58e-03 | 139 | 290 | 6 | C0025363 | |
| Disease | osteoarthritis, spine, body mass index | 2.59e-03 | 8 | 290 | 2 | EFO_0004340, EFO_1000787 | |
| Disease | ovarian cancer (implicated_via_orthology) | 2.59e-03 | 8 | 290 | 2 | DOID:2394 (implicated_via_orthology) | |
| Disease | protein FAM177A1 measurement | 2.59e-03 | 8 | 290 | 2 | EFO_0801948 | |
| Disease | Polycystic Kidney, Type 1 Autosomal Dominant Disease | 2.59e-03 | 8 | 290 | 2 | C0887850 | |
| Disease | Pruritus | 2.59e-03 | 8 | 290 | 2 | C0033774 | |
| Disease | HMG CoA reductase inhibitor use measurement | 2.76e-03 | 189 | 290 | 7 | EFO_0009932 | |
| Disease | hearing impairment | 2.86e-03 | 98 | 290 | 5 | C1384666 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 2.92e-03 | 243 | 290 | 8 | EFO_0004612, EFO_0020944 | |
| Disease | Schizophrenia | DOCK4 ARHGAP32 PAG1 RELN CNNM2 BAG1 DCC PCDH17 ADK HRH1 WNK3 CACNA1C DRD1 TSNARE1 LARS2 AUTS2 ARHGAP18 MYO16 | 3.04e-03 | 883 | 290 | 18 | C0036341 |
| Disease | D dimer measurement | 3.13e-03 | 30 | 290 | 3 | EFO_0004507 | |
| Disease | Generalized seizures | 3.26e-03 | 101 | 290 | 5 | C0234533 | |
| Disease | Clonic Seizures | 3.26e-03 | 101 | 290 | 5 | C0234535 | |
| Disease | Non-epileptic convulsion | 3.26e-03 | 101 | 290 | 5 | C0751056 | |
| Disease | Atonic Absence Seizures | 3.26e-03 | 101 | 290 | 5 | C0751123 | |
| Disease | Single Seizure | 3.26e-03 | 101 | 290 | 5 | C0751110 | |
| Disease | Visual seizure | 3.26e-03 | 101 | 290 | 5 | C0270824 | |
| Disease | Epileptic drop attack | 3.26e-03 | 101 | 290 | 5 | C0270846 | |
| Disease | Vertiginous seizure | 3.26e-03 | 101 | 290 | 5 | C0422855 | |
| Disease | Gustatory seizure | 3.26e-03 | 101 | 290 | 5 | C0422854 | |
| Disease | Seizures, Somatosensory | 3.26e-03 | 101 | 290 | 5 | C0422850 | |
| Disease | Olfactory seizure | 3.26e-03 | 101 | 290 | 5 | C0422853 | |
| Disease | Seizures, Auditory | 3.26e-03 | 101 | 290 | 5 | C0422852 | |
| Disease | Convulsive Seizures | 3.26e-03 | 101 | 290 | 5 | C0751494 | |
| Disease | Seizures, Sensory | 3.26e-03 | 101 | 290 | 5 | C0751496 | |
| Disease | Complex partial seizures | 3.26e-03 | 101 | 290 | 5 | C0149958 | |
| Disease | Nonepileptic Seizures | 3.26e-03 | 101 | 290 | 5 | C3495874 | |
| Disease | Generalized Absence Seizures | 3.26e-03 | 101 | 290 | 5 | C4505436 | |
| Disease | Jacksonian Seizure | 3.26e-03 | 101 | 290 | 5 | C0022333 | |
| Disease | Epileptic Seizures | 3.26e-03 | 101 | 290 | 5 | C4317109 | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 3.31e-03 | 9 | 290 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | spinal muscular atrophy (implicated_via_orthology) | 3.31e-03 | 9 | 290 | 2 | DOID:12377 (implicated_via_orthology) | |
| Disease | Luft Disease | 3.31e-03 | 9 | 290 | 2 | C0949496 | |
| Disease | Focal Segmental Glomerulosclerosis, Not Otherwise Specified | 3.31e-03 | 9 | 290 | 2 | C4049702 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QEAIQEGIASATMFD | 436 | Q96P26 | |
| SEVRSVASNQSEMEF | 671 | Q8N163 | |
| QEFMTSHSEAGSRIV | 431 | Q9BRR6 | |
| RTGVRFVQETDDMTQ | 146 | Q6ZU80 | |
| MADFVQTRAASILSD | 211 | P11597 | |
| FTQGRDDTIMATESE | 281 | P55263 | |
| DDTIMATESEVTAFA | 286 | P55263 | |
| MAAAVVVAEGDSDSR | 1 | Q9UJX6 | |
| VSTSDGTRIERDDAM | 1571 | Q9NR09 | |
| GDTISLIFTDFQMEE | 276 | Q7Z407 | |
| MEGSGDAAFRDTQTS | 1956 | P13611 | |
| GSETLTDSFVLMANA | 1436 | Q6UVK1 | |
| MELSAVGERVFAAES | 1 | O95503 | |
| QVTVEGSSAMAEFSV | 371 | Q6QNK2 | |
| GEMTSEEFRQVVNGF | 26 | Q5NE16 | |
| AIEDMGFEASVVSES | 416 | P35670 | |
| RISSDFEVGDSMASE | 376 | Q9H9E3 | |
| SSMDLGRVDSFNDTN | 61 | Q8IUA7 | |
| TVRKQTESSFMAGDI | 1156 | O94910 | |
| QSIADARLVFEMGTE | 211 | Q96A70 | |
| QEVAVLEASSSEDMG | 416 | Q8N556 | |
| SGASSMDVARLVEEI | 371 | Q3SY69 | |
| IMATGVQDFNRTEFD | 61 | Q6IC98 | |
| RQMASFQESVGETSS | 1051 | Q9Y6D5 | |
| VLDATFVMVARDSEN | 196 | Q9Y305 | |
| ADEVISSMRTVAAFG | 281 | O95342 | |
| SEEVTREEMAAAGLT | 131 | Q99933 | |
| EMRGSEDAAAGTVLQ | 86 | Q8IY63 | |
| MDSSDLSDGAVTLQE | 411 | Q9Y2X7 | |
| MDGESEVDFSSNSIT | 1 | Q96DR7 | |
| LSFEDANRAMQTGVT | 501 | Q96G46 | |
| TSAMDGTGLVVERDF | 6 | P21728 | |
| DTLDDIMAAVSGRAS | 1021 | O75179 | |
| MTAAENGQTAAVEFL | 896 | Q8NB46 | |
| TTMRENLATVEGNFA | 376 | Q13561 | |
| IESMAITEAFGEFRT | 116 | Q14565 | |
| SEMVLADDNFSTIVA | 731 | O14983 | |
| EERGMGALIATNTTE | 986 | Q76L83 | |
| EMSGDVRDAFVAIVQ | 581 | P08133 | |
| FSVIAMTDVEAGTQE | 416 | P17342 | |
| LTDGVVSDMAETRTA | 441 | O95741 | |
| AEEVGTFSMASEEVL | 21 | Q9UKX7 | |
| MVAFESRDEATAAVI | 901 | Q9NTZ6 | |
| GMFLSQEDVEAVSAN | 316 | Q9UKL0 | |
| QFVEMVNGTDSEVRS | 336 | Q6VN20 | |
| RASRDSSEMGAVLEQ | 1106 | O14917 | |
| MFLETSALTGENVEE | 151 | P20338 | |
| MFLETSALTGENVEE | 146 | P61018 | |
| FVMAVSVDGRTFEGS | 306 | Q9NS39 | |
| SMTAGVSEREANDAL | 61 | Q68E01 | |
| STLVSMAQSGDRDEF | 171 | Q8N130 | |
| GMDDTQVRSAATDIF | 371 | Q6IN85 | |
| FDSTTANMNLDRIGE | 1016 | Q14573 | |
| SKMTDVESGVANFAS | 6 | Q9C010 | |
| MVTDDFVVSGTCAEQ | 131 | P49720 | |
| VANEERGMFLISASS | 1146 | Q8N1W1 | |
| LAEVVESMFRESGFQ | 896 | Q9NRD9 | |
| TAATFMEVIAEDNRF | 596 | P0C881 | |
| TAATFMEVIAEDNRF | 596 | B2RC85 | |
| IFMGEIEENSASNSL | 161 | P32926 | |
| SFMAVDQEETVLEGT | 11 | Q6P3S6 | |
| RFLSQTESVTAFMGD | 141 | P43146 | |
| MTNNEDVSGAFVTLR | 276 | Q9UK17 | |
| FVVFTEEESGMSDQL | 1546 | Q14667 | |
| GSEVEELSEVSNFTM | 1766 | Q86XX4 | |
| AVAFSSTVSEFLMGE | 211 | Q92619 | |
| IQTAMDEAFTVEAGA | 166 | O15232 | |
| SVEDRFSDDQLVSMS | 206 | Q9Y5Q3 | |
| AQDRIATTDDTTAMA | 341 | P43363 | |
| MTSAGVFNAGSDERA | 1 | Q9BZ81 | |
| DTVASIFGSTMGEIR | 451 | Q9UPQ8 | |
| GTNEVFMIDRDNSVF | 306 | O60942 | |
| SFVNVNFEMEGDSEV | 186 | Q8N128 | |
| EGFTSQEDQEMLSRI | 661 | P33992 | |
| FDFSATDVMDIIINS | 341 | Q9H9P8 | |
| QMEDSEGTVRQIGAF | 961 | Q86W92 | |
| AMEVLGFSSEDQDSI | 1461 | Q9UKN7 | |
| REAEGFETNMNISSR | 1696 | Q9Y6X6 | |
| AVQSAMAVIGFSEEE | 246 | Q9UBC5 | |
| MAERSTNVAIAETAE | 556 | Q8IYT1 | |
| DEASEGDMSISILTQ | 881 | P46020 | |
| TLNSMDATSERDFVA | 226 | P04424 | |
| SGKMDENRFVAVTST | 366 | Q14117 | |
| SDVNGSTESFEMVIE | 686 | Q658Y4 | |
| KGNADEFTIESVTMR | 601 | Q8IVV2 | |
| SGGSEQRDTSDAVVM | 566 | Q8WVS4 | |
| AEVVESMFRESGFQD | 901 | Q9NRD8 | |
| TFATDDRKEGMTAFV | 266 | P30084 | |
| EAQSSFSMRDRGTVA | 1351 | P51805 | |
| FLDELESVMSQRGTA | 351 | Q8IYT4 | |
| TETRDLRNMTVADSG | 1591 | O60437 | |
| SSGEESEEDVLFSNM | 231 | Q9H792 | |
| ENNMEETGSLDSFSI | 181 | Q9UM44 | |
| TSAEEDIIDGFAMTS | 81 | Q8WXX7 | |
| MGFFSLSSERNESVI | 1 | Q99550 | |
| SDQESFREVITAMDV | 301 | Q9HD67 | |
| AMVTGEQRTEALTEA | 376 | Q6ZMV9 | |
| ESEAVATSGNTDVMQ | 236 | O94854 | |
| ATSGNTDVMQESRFS | 241 | O94854 | |
| STEQMLSSEAVAVDF | 301 | Q01650 | |
| AGMDGSSRFIIINSE | 166 | O75581 | |
| MASSAEGDEGTVVAL | 1 | Q6P1A2 | |
| LSDSDMFSQAGLRSE | 501 | P42704 | |
| GATVFETDVMVSSDG | 251 | Q9HCC8 | |
| MEFDDQATVEINSSG | 1706 | Q07864 | |
| MTQDELRSLFSSIGE | 31 | Q15717 | |
| DMDAVLSDFVRSTGA | 26 | Q8TE49 | |
| MEETERGSFVANLAN | 36 | Q9Y5E8 | |
| GMEQEERTAVFQEFS | 561 | Q9H8H2 | |
| ESACFSGTAAFMEVR | 536 | A7KAX9 | |
| MAAVAVAVREDSGSG | 1 | Q9UI10 | |
| ESREAMVAFFNSAVA | 731 | Q08379 | |
| ESTGTVRVFDLMGSE | 151 | A2RRP1 | |
| EDRGVMAVTAVTATA | 121 | Q7Z4V5 | |
| SNEEVAAMIRAGDTT | 651 | Q27J81 | |
| FIMESVQEAVASTSG | 116 | Q8N485 | |
| TDQDMFGDASTSLVV | 461 | Q6VY07 | |
| VDISFNMETGVRAAE | 331 | Q5XG87 | |
| DAVQTSLMDEGASSE | 421 | Q15291 | |
| SGSADQRTVMLDTFS | 2661 | P78509 | |
| MEAANESSEGISFVL | 1 | Q8NGR3 | |
| VMVTAETAEASQTFG | 3151 | Q6V1P9 | |
| MVFSIQDIDSGDNGR | 366 | Q9Y5F2 | |
| ERAKEATISMGSAVF | 1226 | Q9UHC9 | |
| AMAAAAAETSQRIQE | 196 | Q9NV92 | |
| TAVVLVSADRSGMEN | 541 | P20393 | |
| VSADRSGMENSASVE | 546 | P20393 | |
| VNGNIEDAMTAFESI | 661 | A6NKT7 | |
| DESIFSIMIDRNASG | 821 | Q8NCM8 | |
| ASGKMDENEFVAVTS | 371 | O14531 | |
| MSAAEQGSLRESVIE | 631 | A4FU69 | |
| IMNFRTGTVNEDSSE | 191 | O60741 | |
| LSGQFSESRSGRVEM | 126 | Q9NVR0 | |
| MFTGELAESRQTEVV | 96 | Q9Y2M5 | |
| VGIQASEASRMEDAT | 591 | Q0VDD7 | |
| SEASRMEDATNVVRG | 596 | Q0VDD7 | |
| MEELSSVGEQVFAAE | 1 | Q14781 | |
| ALGEDQVAETSAMSD | 196 | Q9Y426 | |
| SRESQAAMAGQEETS | 1901 | Q13936 | |
| RATCGMEEEQFRSSI | 746 | Q8IZD9 | |
| ARNVEVTMFIVDSSG | 421 | Q8N1I0 | |
| RSSSREQEAGVLAMD | 1476 | O14981 | |
| VMREVQSALSTAAAD | 371 | Q9Y232 | |
| FDFMGLRNTTEIVTT | 221 | Q99928 | |
| IIENTRDSTFVFMEG | 321 | Q86XK2 | |
| GFTSLGMEEERIETA | 91 | Q96JB2 | |
| GMEEERIETAQQFFS | 96 | Q96JB2 | |
| ANDSMGDERTAVSLV | 56 | Q6IN97 | |
| NDSMGDERTAVSLVT | 1046 | Q68DX3 | |
| NETRSIIEFGSTMES | 566 | Q96PZ2 | |
| RSEDAGFVVITGVMS | 76 | Q9GZV9 | |
| STMDAISAEGFTDID | 206 | Q9H0C5 | |
| DGSDRVSNSDFVTMT | 1011 | A8TX70 | |
| MVTSVDGSQQVAFDD | 321 | Q8IZJ3 | |
| IFTMSVEVDGNSFEA | 431 | Q12906 | |
| TMGSDSDEENVAARA | 286 | Q9BYX4 | |
| MELSAIGEQVFAVES | 1 | O95931 | |
| LESTMGVEEDAVAAT | 451 | Q5T0F9 | |
| ANDADDSTTANGMVR | 301 | P55283 | |
| LDEGTVRSMVTEEFN | 241 | Q7Z7K6 | |
| MSFFGSALSIDETRA | 21 | Q9NZK5 | |
| SAAGDTVDKNTVEFM | 951 | Q5TB80 | |
| RVSTDDVFAVLDSMG | 236 | Q8IY85 | |
| SRSIDGLFMDFATQT | 416 | Q9UH90 | |
| TTNIMEILRGDFSSA | 106 | P02671 | |
| MLGEFVSETESRGSE | 536 | P02671 | |
| EDGQVMDVDLSTAST | 151 | P01854 | |
| LSEDNSSGEVVMRVT | 386 | A6NNE9 | |
| MASTGSQASDIDEIF | 1 | Q9BPY3 | |
| MAGEVSAATGRFSLE | 1 | O75881 | |
| DGSFLVVNADTVEDM | 1061 | Q6ZMW3 | |
| AEGFSDTALIMVDNT | 116 | O43402 | |
| EASIGSMVSRVDAEE | 396 | Q96AY2 | |
| ISEDQMLGDSQSFSR | 346 | P35367 | |
| MGSTFEDDQEVIRFQ | 181 | Q6UW02 | |
| DIEDFRQATAASSVM | 226 | Q9NX74 | |
| EREGQVEAGIMTATT | 711 | Q5T890 | |
| EVDSKAENGMTFSRL | 536 | Q8TDG4 | |
| QAGETEEAETVSAMA | 1076 | Q9UQL6 | |
| AQTTSEAAMEGATLD | 991 | Q9UBN7 | |
| EAAMEGATLDQTTSE | 996 | Q9UBN7 | |
| ASAGENETFVMRLTV | 226 | Q15762 | |
| MTALSRSEATEEGGN | 1 | Q8IUY3 | |
| TALARGDMVSAEIAS | 251 | Q99946 | |
| GDMVSAEIASREARN | 256 | Q99946 | |
| LSTASGELQVDASFM | 181 | P21817 | |
| EVLMSDSGSETAFRE | 1166 | P21817 | |
| TRDEFFMEAIEAVSG | 261 | P55291 | |
| DTSSADRQTRMEGAE | 501 | Q99661 | |
| GTSVMQVTATDEDDA | 231 | P22223 | |
| DFETNRMFVLTVAAE | 451 | P19022 | |
| QMLTEENSRDDSGAS | 16 | Q6W0C5 | |
| AEASEEAVSVQRSMQ | 861 | P30622 | |
| DDDGMSVYTDTIQQR | 1016 | Q13615 | |
| VFGDLDQVRMTSEGS | 31 | Q68BL7 | |
| VEMARVGGASSLENT | 376 | Q14653 | |
| SGSSEDSFVEIRMAE | 171 | Q96CV9 | |
| MGVLSSSEELFSQED | 226 | Q6ZUA9 | |
| EEALSSGSVQEAEAM | 116 | Q96S52 | |
| TVMFDLSETGINSID | 146 | Q8NHP6 | |
| LSETGINSIDMDFVR | 151 | Q8NHP6 | |
| LDTVVTSEDGDANTM | 36 | Q9Y4G2 | |
| IESRGLFSSDSGIEM | 156 | Q16799 | |
| MFIEDRAVSSTELSA | 266 | A2RTX5 | |
| FENSMDLAAIEGTSQ | 281 | Q8TDW5 | |
| DVASMAGVNLSEESA | 836 | O00268 | |
| TSMAGDTSVRIFEQH | 2566 | Q5T011 | |
| VAVAGTELFRDSGTM | 391 | Q9NYH9 | |
| VNGNIEDAMTAFESI | 661 | Q7Z3J3 | |
| ENFISRAFATMGETV | 16 | Q9NX07 | |
| DAETFSEGEMVTFIN | 556 | P07814 | |
| TDVRGLEEFLSAMQS | 471 | Q494U1 | |
| NMEESTNGSLAAEFR | 391 | P42224 | |
| SVQNTSRDMEASEEG | 426 | Q93075 | |
| TEGSLEMETAFNSRG | 301 | Q17RD7 | |
| ASSQDEQITAIDRGM | 981 | Q14C87 | |
| MDDGVSSFVQIRGSV | 241 | O15056 | |
| SAEFTGMTRQDAFLA | 411 | Q15031 | |
| EVAAATTMEATSREA | 16 | Q15345 | |
| RNEGTLAEMAAATSV | 411 | Q68EM7 | |
| DASGSMRVTVVAEEN | 256 | Q9Y6U3 | |
| VVSADQEMSGRAAAT | 446 | Q8N3V7 | |
| FTVDAAMVAVSNGDL | 206 | Q6P1X5 | |
| GSFSTADQLEMVTEL | 91 | P01106 | |
| TNFGISSVDLSVMED | 41 | P37231 | |
| SRSSMDGAGAEEVLA | 51 | P41250 | |
| MFEGEVASLEALRST | 51 | Q9H479 | |
| RGMSEEEVFTEVANL | 206 | O75182 | |
| GSDSQVTRALMEQFE | 331 | Q86YJ6 | |
| QAMIEEAITRAESFS | 311 | Q9BXB7 | |
| DSQRVSMRTGDQDSI | 216 | Q13203 | |
| SQSEENISGMTSFRE | 1646 | O75592 | |
| SVFGSTAERMRQEGA | 771 | Q5T8A7 | |
| ASSRIRETMANSAGF | 376 | Q9P202 | |
| FSNVDISELSSEVMG | 261 | P57073 | |
| TSIFEMGTNFSESVE | 146 | Q9BZV3 | |
| EEIDMAFQQSGTAAD | 61 | O75381 | |
| SSSVGEVNFRSELMF | 91 | Q4LDE5 | |
| AVDTMLTARSVDGDQ | 141 | Q9NWQ8 | |
| TTDQRMSATGFEETD | 231 | P11831 | |
| DTSEMVNGATEQRTS | 2146 | Q01082 | |
| FAATSSMGLETEEQE | 466 | Q08188 | |
| RNSEDDGVVMTFSSV | 201 | Q9NY61 | |
| DREDAQTGSVAAGIM | 751 | Q0VD83 | |
| ERGLSSFQQSVAMDR | 146 | Q8N365 | |
| SFEDVLGMASVFSEQ | 81 | A0PJX0 | |
| MESRVADAGTGETAR | 1 | Q7Z624 | |
| MAAAQEADGARSAVV | 1 | O96005 | |
| DQGAEDVVMAFSRSE | 61 | Q9NSA3 | |
| VSAMRVLNTGSDVEE | 586 | O75122 | |
| DTNDVSFMEGGALRV | 81 | Q9H8M5 | |
| VMAETTDNVFTLDAD | 336 | Q7LG56 | |
| ISVSEDMNSEGNVDF | 406 | Q5QJE6 | |
| ASATEMRTTFQEESA | 3326 | A4UGR9 | |
| QIESSMTDLDASFGL | 286 | Q86WB0 | |
| MDSVASEDVAVNFTL | 1 | Q8TBZ8 | |
| LTGRVVEDMEGASQA | 616 | Q8N5D0 | |
| VDMAGLQTSFLSQDE | 941 | P82094 | |
| VVSASFDDSVDMGVV | 1396 | Q96KV7 | |
| AEASLSAEQGTMTEV | 46 | Q5T7W0 | |
| GSERMTELADVFSGV | 446 | Q12768 | |
| MVSEQGEAVDSIEAS | 446 | Q96NA8 | |
| NVDGFGLEAEARMTT | 2156 | Q8IZQ1 | |
| EVVFVSADGSSQEML | 66 | Q5VZ03 | |
| MATAESRALQFAEGA | 1 | Q9H2W2 | |
| KSFNATAERGEEMTF | 216 | O15394 | |
| QDTEESIVLGMDFSS | 116 | Q76I76 | |
| RTGDAISVMSEVAQT | 151 | Q99943 | |
| AEFSVDETGQMSATA | 61 | P02753 | |
| IEGIVMAADSARSFS | 146 | Q86TD4 | |
| ESERVQVEGGMESSL | 341 | Q99592 | |
| MEDFTFDGTKRLSVN | 6 | O75897 | |
| NQTDSGMVLASEEFE | 1271 | P35916 | |
| ATMLGRTNISDEESE | 1071 | P18206 | |
| FLNSVDEMDTGDTIN | 416 | P46937 | |
| MDSVAFEDVAVNFTL | 1 | Q7L945 | |
| DMRVRNESSFSASLG | 771 | Q5JSZ5 | |
| VIGESDIMQEFLSES | 251 | Q96L92 | |
| SLVTGGEDDRMSVNS | 1051 | Q8WVM7 | |
| SRRVDMAALFQEASS | 86 | O75678 | |
| GFEILTNEERTMTEA | 186 | Q86XW9 | |
| EANDSGETMRVAIFA | 326 | Q9Y279 | |
| QSSFMVSLGVSERAE | 486 | Q6UXZ4 | |
| SSEQREFVMAAGTAN | 496 | Q8N392 | |
| EEGISEFSRMVLNSF | 36 | Q8NAM6 | |
| SVVAVGEAMAFEISN | 746 | A8K0R7 | |
| VVEFRDSQATAMSVD | 11 | Q6PJI9 | |
| FSIFGQMAVSSDVVE | 2571 | Q7Z7G8 | |
| GRVSFASTDEQDAMD | 506 | Q9UIA9 | |
| MSQGSVTFRDVAIDF | 1 | P52738 | |
| FSTAGNDAVEEMVCV | 301 | Q9H892 | |
| TEVLESNGMIDAART | 246 | Q13342 | |
| ANRGSAEDVAMQVEA | 571 | P22735 | |
| NIGSELSDTDISMFV | 556 | Q8WY21 | |
| FTDVATGEMSRELAD | 806 | Q6P3X3 | |
| GSTRSENLDVFSEMN | 1271 | Q9Y6X0 | |
| RSTFTDSQLGNADME | 336 | Q99959 | |
| EAEDFISGITQTMVE | 1246 | Q14966 | |
| ASDEGRVQMTAAAFA | 576 | Q6PFW1 | |
| VSIDTDMVEFQAGSE | 1481 | Q7Z3T8 | |
| MDSVSFEDVAVAFTQ | 1 | Q9BS34 | |
| MDSVSFEDVAVNFTL | 1 | P17017 | |
| MDAEFISQEGETTVN | 1051 | Q9BYP7 | |
| SQELVTFEDVSMDFS | 41 | Q86TJ5 | |
| RSQFGSAAEMLSEQT | 6 | Q96N77 | |
| SRVAKMLADEFGTAS | 46 | P62495 | |
| GTDRIEVANTDGSMR | 836 | O75096 | |
| AANAAGEATAMVEVS | 361 | Q9ULH4 | |
| ADRFMSSIEVITSQE | 96 | P32418 | |
| QFMEAITVSAAGDED | 701 | P57103 | |
| MASAAAGEAEETTRL | 1 | Q86VE0 |